id	sid	tid	token	lemma	pos
njb-33	1	1	nepal	nepal	ADJ
njb-33	1	2	journal	journal	NOUN
njb-33	1	3	of	of	ADP
njb-33	1	4	biotechnology	biotechnology	NOUN
njb-33	1	5	.	.	PUNCT
njb-33	2	1	d	d	X
njb-33	2	2	e	e	PROPN
njb-33	2	3	c	c	PROPN
njb-33	2	4	.	.	PUNCT
njb-33	3	1	2	2	NUM
njb-33	3	2	0	0	NUM
njb-33	3	3	1	1	NUM
njb-33	3	4	5	5	NUM
njb-33	3	5	vol	vol	NOUN
njb-33	3	6	.	.	PUNCT
njb-33	4	1	3	3	NUM
njb-33	4	2	,	,	PUNCT
njb-33	4	3	no	no	INTJ
njb-33	4	4	.	.	NOUN
njb-33	5	1	1:55	1:55	NUM
njb-33	5	2	-	-	SYM
njb-33	5	3	59	59	NUM
njb-33	5	4	issn	issn	PROPN
njb-33	5	5	2091	2091	NUM
njb-33	5	6	-	-	SYM
njb-33	5	7	1130	1130	NUM
njb-33	5	8	(	(	PUNCT
njb-33	5	9	print	print	NOUN
njb-33	5	10	)	)	PUNCT
njb-33	5	11	/	/	PUNCT
njb-33	5	12	issn	issn	PROPN
njb-33	5	13	2467	2467	NUM
njb-33	5	14	-	-	SYM
njb-33	5	15	9319	9319	NUM
njb-33	5	16	(	(	PUNCT
njb-33	5	17	online	online	ADJ
njb-33	5	18	)	)	PUNCT
njb-33	5	19	original	original	ADJ
njb-33	5	20	research	research	NOUN
njb-33	5	21	article	article	NOUN
njb-33	5	22	©	©	PROPN
njb-33	5	23	njb	njb	PROPN
njb-33	5	24	,	,	PUNCT
njb-33	5	25	biotechnology	biotechnology	NOUN
njb-33	5	26	society	society	NOUN
njb-33	5	27	of	of	ADP
njb-33	5	28	nepal	nepal	ADJ
njb-33	5	29	55	55	NUM
njb-33	5	30	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-33	5	31	prevalence	prevalence	NOUN
njb-33	5	32	of	of	ADP
njb-33	5	33	multidrug	multidrug	NOUN
njb-33	5	34	resistant	resistant	ADJ
njb-33	5	35	bacteria	bacteria	NOUN
njb-33	5	36	in	in	ADP
njb-33	5	37	causing	cause	VERB
njb-33	5	38	community	community	NOUN
njb-33	5	39	acquired	acquire	VERB
njb-33	5	40	urinary	urinary	ADJ
njb-33	5	41	tract	tract	NOUN
njb-33	5	42	infection	infection	NOUN
njb-33	5	43	among	among	ADP
njb-33	5	44	the	the	DET
njb-33	5	45	patients	patient	NOUN
njb-33	5	46	attending	attend	VERB
njb-33	5	47	outpatient	outpatient	NOUN
njb-33	5	48	department	department	NOUN
njb-33	5	49	of	of	ADP
njb-33	5	50	seti	seti	PROPN
njb-33	5	51	zonal	zonal	ADJ
njb-33	5	52	hospital	hospital	NOUN
njb-33	5	53	,	,	PUNCT
njb-33	5	54	dhangadi	dhangadi	NOUN
njb-33	5	55	,	,	PUNCT
njb-33	5	56	nepal	nepal	ADJ
njb-33	5	57	tek	tek	PROPN
njb-33	5	58	raj	raj	PROPN
njb-33	5	59	awasthi1	awasthi1	PROPN
njb-33	5	60	,	,	PUNCT
njb-33	5	61	narayan	narayan	PROPN
njb-33	5	62	dutt	dutt	PROPN
njb-33	5	63	pant2	pant2	PROPN
njb-33	5	64	*	*	PROPN
njb-33	5	65	,	,	PUNCT
njb-33	5	66	puspa	puspa	PROPN
njb-33	5	67	raj	raj	PROPN
njb-33	5	68	dahal3	dahal3	PROPN
njb-33	5	69	1department	1department	NUM
njb-33	5	70	of	of	ADP
njb-33	5	71	microbiology	microbiology	NOUN
njb-33	5	72	,	,	PUNCT
njb-33	5	73	siddhanath	siddhanath	NOUN
njb-33	5	74	science	science	PROPN
njb-33	5	75	campus	campus	PROPN
njb-33	5	76	,	,	PUNCT
njb-33	5	77	kanchanpur	kanchanpur	PROPN
njb-33	5	78	,	,	PUNCT
njb-33	5	79	nepal	nepal	PROPN
njb-33	5	80	2department	2department	NUM
njb-33	5	81	of	of	ADP
njb-33	5	82	microbiology	microbiology	NOUN
njb-33	5	83	,	,	PUNCT
njb-33	5	84	grande	grande	ADJ
njb-33	5	85	international	international	ADJ
njb-33	5	86	hospital	hospital	NOUN
njb-33	5	87	,	,	PUNCT
njb-33	5	88	dhapasi	dhapasi	NOUN
njb-33	5	89	,	,	PUNCT
njb-33	5	90	kathmandu	kathmandu	NOUN
njb-33	5	91	,	,	PUNCT
njb-33	5	92	nepal	nepal	ADJ
njb-33	5	93	3department	3department	NUM
njb-33	5	94	of	of	ADP
njb-33	5	95	microbiology	microbiology	NOUN
njb-33	5	96	,	,	PUNCT
njb-33	5	97	trichandra	trichandra	VERB
njb-33	5	98	multiple	multiple	ADJ
njb-33	5	99	college	college	NOUN
njb-33	5	100	,	,	PUNCT
njb-33	5	101	kathmandu	kathmandu	NOUN
njb-33	5	102	,	,	PUNCT
njb-33	5	103	nepal	nepal	ADJ
njb-33	5	104	abstract	abstract	ADJ
njb-33	5	105	involvement	involvement	NOUN
njb-33	5	106	of	of	ADP
njb-33	5	107	multidrug	multidrug	NOUN
njb-33	5	108	resistant	resistant	ADJ
njb-33	5	109	bacteria	bacteria	NOUN
njb-33	5	110	in	in	ADP
njb-33	5	111	causing	cause	VERB
njb-33	5	112	community	community	NOUN
njb-33	5	113	acquired	acquire	VERB
njb-33	5	114	infection	infection	NOUN
njb-33	5	115	is	be	AUX
njb-33	5	116	very	very	ADV
njb-33	5	117	serious	serious	ADJ
njb-33	5	118	public	public	ADJ
njb-33	5	119	health	health	NOUN
njb-33	5	120	issue	issue	NOUN
njb-33	5	121	.	.	PUNCT
njb-33	6	1	the	the	DET
njb-33	6	2	main	main	ADJ
njb-33	6	3	objective	objective	NOUN
njb-33	6	4	of	of	ADP
njb-33	6	5	our	our	PRON
njb-33	6	6	study	study	NOUN
njb-33	6	7	was	be	AUX
njb-33	6	8	to	to	PART
njb-33	6	9	determine	determine	VERB
njb-33	6	10	the	the	DET
njb-33	6	11	prevalence	prevalence	NOUN
njb-33	6	12	of	of	ADP
njb-33	6	13	multidrug	multidrug	NOUN
njb-33	6	14	resistant	resistant	ADJ
njb-33	6	15	bacteria	bacteria	NOUN
njb-33	6	16	in	in	ADP
njb-33	6	17	causing	cause	VERB
njb-33	6	18	community	community	NOUN
njb-33	6	19	acquired	acquire	VERB
njb-33	6	20	urinary	urinary	ADJ
njb-33	6	21	tract	tract	NOUN
njb-33	6	22	infection	infection	NOUN
njb-33	6	23	.	.	PUNCT
njb-33	7	1	in	in	ADP
njb-33	7	2	this	this	DET
njb-33	7	3	study	study	NOUN
njb-33	7	4	we	we	PRON
njb-33	7	5	cultured	culture	VERB
njb-33	7	6	the	the	DET
njb-33	7	7	384	384	NUM
njb-33	7	8	mid	mid	ADJ
njb-33	7	9	stream	stream	NOUN
njb-33	7	10	urine	urine	NOUN
njb-33	7	11	samples	sample	NOUN
njb-33	7	12	collected	collect	VERB
njb-33	7	13	aseptically	aseptically	ADV
njb-33	7	14	from	from	ADP
njb-33	7	15	the	the	DET
njb-33	7	16	patients	patient	NOUN
njb-33	7	17	attending	attend	VERB
njb-33	7	18	outpatient	outpatient	NOUN
njb-33	7	19	department	department	NOUN
njb-33	7	20	of	of	ADP
njb-33	7	21	seti	seti	PROPN
njb-33	7	22	zonal	zonal	ADJ
njb-33	7	23	hospital	hospital	NOUN
njb-33	7	24	and	and	CCONJ
njb-33	7	25	having	have	VERB
njb-33	7	26	no	no	DET
njb-33	7	27	past	past	ADJ
njb-33	7	28	history	history	NOUN
njb-33	7	29	of	of	ADP
njb-33	7	30	hospitalization	hospitalization	NOUN
njb-33	7	31	.	.	PUNCT
njb-33	8	1	the	the	DET
njb-33	8	2	organisms	organism	NOUN
njb-33	8	3	isolated	isolate	VERB
njb-33	8	4	were	be	AUX
njb-33	8	5	identified	identify	VERB
njb-33	8	6	by	by	ADP
njb-33	8	7	using	use	VERB
njb-33	8	8	conventional	conventional	ADJ
njb-33	8	9	biochemical	biochemical	ADJ
njb-33	8	10	tests	test	NOUN
njb-33	8	11	and	and	CCONJ
njb-33	8	12	antimicrobial	antimicrobial	ADJ
njb-33	8	13	susceptibility	susceptibility	NOUN
njb-33	8	14	testing	testing	NOUN
njb-33	8	15	was	be	AUX
njb-33	8	16	performed	perform	VERB
njb-33	8	17	by	by	ADP
njb-33	8	18	kirby	kirby	PROPN
njb-33	8	19	bauer	bauer	PROPN
njb-33	8	20	disc	disc	NOUN
njb-33	8	21	diffusion	diffusion	NOUN
njb-33	8	22	technique	technique	NOUN
njb-33	8	23	.	.	PUNCT
njb-33	9	1	out	out	ADP
njb-33	9	2	of	of	ADP
njb-33	9	3	total	total	ADJ
njb-33	9	4	384	384	NUM
njb-33	9	5	samples	sample	NOUN
njb-33	9	6	98	98	NUM
njb-33	9	7	(	(	PUNCT
njb-33	9	8	25.52	25.52	NUM
njb-33	9	9	%	%	NOUN
njb-33	9	10	)	)	PUNCT
njb-33	9	11	samples	sample	NOUN
njb-33	9	12	showed	show	VERB
njb-33	9	13	significant	significant	ADJ
njb-33	9	14	bacterial	bacterial	ADJ
njb-33	9	15	growth	growth	NOUN
njb-33	9	16	.	.	PUNCT
njb-33	10	1	the	the	DET
njb-33	10	2	most	most	ADV
njb-33	10	3	prevalent	prevalent	ADJ
njb-33	10	4	bacterium	bacterium	NOUN
njb-33	10	5	isolated	isolate	VERB
njb-33	10	6	was	be	AUX
njb-33	10	7	escherichia	escherichia	NOUN
njb-33	10	8	coli	coli	NOUN
njb-33	10	9	.	.	PUNCT
njb-33	11	1	42.86	42.86	NUM
njb-33	11	2	%	%	NOUN
njb-33	11	3	of	of	ADP
njb-33	11	4	the	the	DET
njb-33	11	5	bacteria	bacteria	NOUN
njb-33	11	6	isolated	isolate	VERB
njb-33	11	7	were	be	AUX
njb-33	11	8	found	find	VERB
njb-33	11	9	to	to	PART
njb-33	11	10	be	be	AUX
njb-33	11	11	multidrug	multidrug	NOUN
njb-33	11	12	resistant	resistant	ADJ
njb-33	11	13	(	(	PUNCT
njb-33	11	14	mdr	mdr	PROPN
njb-33	11	15	)	)	PUNCT
njb-33	11	16	.	.	PUNCT
njb-33	12	1	the	the	DET
njb-33	12	2	involvement	involvement	NOUN
njb-33	12	3	of	of	ADP
njb-33	12	4	such	such	ADJ
njb-33	12	5	large	large	ADJ
njb-33	12	6	numbers	number	NOUN
njb-33	12	7	of	of	ADP
njb-33	12	8	multidrug	multidrug	NOUN
njb-33	12	9	resistant	resistant	ADJ
njb-33	12	10	bacteria	bacteria	NOUN
njb-33	12	11	in	in	ADP
njb-33	12	12	causing	cause	VERB
njb-33	12	13	community	community	NOUN
njb-33	12	14	acquired	acquire	VERB
njb-33	12	15	urinary	urinary	ADJ
njb-33	12	16	tract	tract	NOUN
njb-33	12	17	infection	infection	NOUN
njb-33	12	18	is	be	AUX
njb-33	12	19	very	very	ADV
njb-33	12	20	serious	serious	ADJ
njb-33	12	21	issue	issue	NOUN
njb-33	12	22	and	and	CCONJ
njb-33	12	23	can	can	AUX
njb-33	12	24	not	not	PART
njb-33	12	25	be	be	AUX
njb-33	12	26	neglected	neglect	VERB
njb-33	12	27	.	.	PUNCT
njb-33	13	1	and	and	CCONJ
njb-33	13	2	some	some	DET
njb-33	13	3	abrupt	abrupt	ADJ
njb-33	13	4	initiatives	initiative	NOUN
njb-33	13	5	should	should	AUX
njb-33	13	6	be	be	AUX
njb-33	13	7	taken	take	VERB
njb-33	13	8	by	by	ADP
njb-33	13	9	the	the	DET
njb-33	13	10	responsible	responsible	ADJ
njb-33	13	11	authorities	authority	NOUN
njb-33	13	12	to	to	PART
njb-33	13	13	improve	improve	VERB
njb-33	13	14	or	or	CCONJ
njb-33	13	15	at	at	ADP
njb-33	13	16	least	least	ADJ
njb-33	13	17	avoid	avoid	VERB
njb-33	13	18	the	the	DET
njb-33	13	19	further	further	ADJ
njb-33	13	20	worsening	worsening	NOUN
njb-33	13	21	of	of	ADP
njb-33	13	22	the	the	DET
njb-33	13	23	situation	situation	NOUN
njb-33	13	24	.	.	PUNCT
njb-33	14	1	key	key	ADJ
njb-33	14	2	words	word	NOUN
njb-33	14	3	:	:	PUNCT
njb-33	14	4	pyelonephritis	pyelonephritis	NOUN
njb-33	14	5	,	,	PUNCT
njb-33	14	6	bacteriuria	bacteriuria	NOUN
njb-33	14	7	cystine	cystine	NOUN
njb-33	14	8	lactose	lactose	NOUN
njb-33	14	9	electrolyte	electrolyte	NOUN
njb-33	14	10	deficient	deficient	NOUN
njb-33	14	11	(	(	PUNCT
njb-33	14	12	cled	cle	VERB
njb-33	14	13	)	)	PUNCT
njb-33	14	14	agar	agar	NOUN
njb-33	14	15	,	,	PUNCT
njb-33	14	16	clsi	clsi	NOUN
njb-33	14	17	*	*	PUNCT
njb-33	14	18	corresponding	correspond	VERB
njb-33	14	19	author	author	NOUN
njb-33	14	20	email	email	NOUN
njb-33	14	21	:	:	PUNCT
njb-33	14	22	ndpant1987@gmail.com	ndpant1987@gmail.com	X
njb-33	14	23	introduction	introduction	NOUN
njb-33	14	24	urinary	urinary	ADJ
njb-33	14	25	tract	tract	NOUN
njb-33	14	26	infection	infection	NOUN
njb-33	14	27	(	(	PUNCT
njb-33	14	28	uti	uti	PROPN
njb-33	14	29	)	)	PUNCT
njb-33	14	30	is	be	AUX
njb-33	14	31	the	the	DET
njb-33	14	32	presence	presence	NOUN
njb-33	14	33	of	of	ADP
njb-33	14	34	multiplying	multiply	VERB
njb-33	14	35	bacteria	bacteria	NOUN
njb-33	14	36	within	within	ADP
njb-33	14	37	the	the	DET
njb-33	14	38	urinary	urinary	ADJ
njb-33	14	39	tract	tract	NOUN
njb-33	14	40	.	.	PUNCT
njb-33	15	1	the	the	DET
njb-33	15	2	presence	presence	NOUN
njb-33	15	3	of	of	ADP
njb-33	15	4	significant	significant	ADJ
njb-33	15	5	numbers	number	NOUN
njb-33	15	6	of	of	ADP
njb-33	15	7	bacteria	bacteria	NOUN
njb-33	15	8	in	in	ADP
njb-33	15	9	aseptically	aseptically	ADV
njb-33	15	10	collected	collect	VERB
njb-33	15	11	urine	urine	NOUN
njb-33	15	12	is	be	AUX
njb-33	15	13	the	the	DET
njb-33	15	14	indication	indication	NOUN
njb-33	15	15	of	of	ADP
njb-33	15	16	urinary	urinary	ADJ
njb-33	15	17	tract	tract	NOUN
njb-33	15	18	infection	infection	NOUN
njb-33	15	19	.	.	PUNCT
njb-33	16	1	despite	despite	SCONJ
njb-33	16	2	the	the	DET
njb-33	16	3	presence	presence	NOUN
njb-33	16	4	of	of	ADP
njb-33	16	5	different	different	ADJ
njb-33	16	6	host	host	NOUN
njb-33	16	7	defense	defense	NOUN
njb-33	16	8	mechanisms	mechanism	NOUN
njb-33	16	9	against	against	ADP
njb-33	16	10	microbial	microbial	ADJ
njb-33	16	11	infection	infection	NOUN
njb-33	16	12	in	in	ADP
njb-33	16	13	urinary	urinary	ADJ
njb-33	16	14	tract	tract	NOUN
njb-33	16	15	,	,	PUNCT
njb-33	16	16	uti	uti	PROPN
njb-33	16	17	is	be	AUX
njb-33	16	18	present	present	ADJ
njb-33	16	19	as	as	ADP
njb-33	16	20	one	one	NUM
njb-33	16	21	of	of	ADP
njb-33	16	22	the	the	DET
njb-33	16	23	commonest	common	ADJ
njb-33	16	24	bacterial	bacterial	ADJ
njb-33	16	25	infections	infection	NOUN
njb-33	16	26	[	[	X
njb-33	16	27	1	1	NUM
njb-33	16	28	]	]	PUNCT
njb-33	16	29	.	.	PUNCT
njb-33	17	1	it	it	PRON
njb-33	17	2	is	be	AUX
njb-33	17	3	an	an	DET
njb-33	17	4	important	important	ADJ
njb-33	17	5	global	global	ADJ
njb-33	17	6	health	health	NOUN
njb-33	17	7	problem	problem	NOUN
njb-33	17	8	affecting	affect	VERB
njb-33	17	9	millions	million	NOUN
njb-33	17	10	of	of	ADP
njb-33	17	11	peoples	people	NOUN
njb-33	17	12	annually	annually	ADV
njb-33	17	13	,	,	PUNCT
njb-33	17	14	from	from	ADP
njb-33	17	15	all	all	DET
njb-33	17	16	age	age	NOUN
njb-33	17	17	groups	group	NOUN
njb-33	17	18	.	.	PUNCT
njb-33	18	1	women	woman	NOUN
njb-33	18	2	are	be	AUX
njb-33	18	3	more	more	ADV
njb-33	18	4	vulnerable	vulnerable	ADJ
njb-33	18	5	to	to	ADP
njb-33	18	6	uti	uti	PROPN
njb-33	18	7	due	due	ADP
njb-33	18	8	to	to	ADP
njb-33	18	9	presence	presence	NOUN
njb-33	18	10	of	of	ADP
njb-33	18	11	shorter	short	ADJ
njb-33	18	12	urethra	urethra	NOUN
njb-33	18	13	and	and	CCONJ
njb-33	18	14	its	its	PRON
njb-33	18	15	proximity	proximity	NOUN
njb-33	18	16	to	to	ADP
njb-33	18	17	perianal	perianal	ADJ
njb-33	18	18	region	region	NOUN
njb-33	18	19	[	[	X
njb-33	18	20	2	2	NUM
njb-33	18	21	]	]	X
njb-33	18	22	.	.	PUNCT
njb-33	19	1	uti	uti	PROPN
njb-33	19	2	in	in	ADP
njb-33	19	3	men	man	NOUN
njb-33	19	4	is	be	AUX
njb-33	19	5	less	less	ADV
njb-33	19	6	common	common	ADJ
njb-33	19	7	in	in	ADP
njb-33	19	8	comparision	comparision	NOUN
njb-33	19	9	to	to	ADP
njb-33	19	10	that	that	PRON
njb-33	19	11	in	in	ADP
njb-33	19	12	women	woman	NOUN
njb-33	19	13	but	but	CCONJ
njb-33	19	14	may	may	AUX
njb-33	19	15	be	be	AUX
njb-33	19	16	very	very	ADV
njb-33	19	17	serious	serious	ADJ
njb-33	19	18	when	when	SCONJ
njb-33	19	19	occurred	occur	VERB
njb-33	19	20	[	[	X
njb-33	19	21	1	1	NUM
njb-33	19	22	]	]	X
njb-33	19	23	.	.	PUNCT
njb-33	20	1	people	people	NOUN
njb-33	20	2	with	with	ADP
njb-33	20	3	defects	defect	NOUN
njb-33	20	4	which	which	PRON
njb-33	20	5	cause	cause	VERB
njb-33	20	6	the	the	DET
njb-33	20	7	retention	retention	NOUN
njb-33	20	8	of	of	ADP
njb-33	20	9	the	the	DET
njb-33	20	10	urine	urine	NOUN
njb-33	20	11	are	be	AUX
njb-33	20	12	at	at	ADP
njb-33	20	13	high	high	ADJ
njb-33	20	14	risk	risk	NOUN
njb-33	20	15	of	of	ADP
njb-33	20	16	getting	get	VERB
njb-33	20	17	uti	uti	PROPN
njb-33	20	18	.	.	PUNCT
njb-33	21	1	further	far	ADV
njb-33	21	2	increased	increase	VERB
njb-33	21	3	rate	rate	NOUN
njb-33	21	4	of	of	ADP
njb-33	21	5	uti	uti	PROPN
njb-33	21	6	is	be	AUX
njb-33	21	7	seen	see	VERB
njb-33	21	8	in	in	ADP
njb-33	21	9	patients	patient	NOUN
njb-33	21	10	with	with	ADP
njb-33	21	11	catheters	catheter	NOUN
njb-33	21	12	or	or	CCONJ
njb-33	21	13	tubes	tube	NOUN
njb-33	21	14	placed	place	VERB
njb-33	21	15	in	in	ADP
njb-33	21	16	urinary	urinary	ADJ
njb-33	21	17	tract	tract	NOUN
njb-33	21	18	and	and	CCONJ
njb-33	21	19	patients	patient	NOUN
njb-33	21	20	with	with	ADP
njb-33	21	21	problems	problem	NOUN
njb-33	21	22	with	with	ADP
njb-33	21	23	the	the	DET
njb-33	21	24	body	body	NOUN
njb-33	21	25	’s	’s	PART
njb-33	21	26	natural	natural	ADJ
njb-33	21	27	defense	defense	NOUN
njb-33	21	28	mechanisms	mechanism	NOUN
njb-33	21	29	.	.	PUNCT
njb-33	22	1	the	the	DET
njb-33	22	2	most	most	ADV
njb-33	22	3	common	common	ADJ
njb-33	22	4	cause	cause	NOUN
njb-33	22	5	of	of	ADP
njb-33	22	6	uti	uti	PROPN
njb-33	22	7	is	be	AUX
njb-33	22	8	escherichia	escherichia	NOUN
njb-33	22	9	coli	coli	NOUN
njb-33	22	10	.	.	PUNCT
njb-33	23	1	other	other	ADJ
njb-33	23	2	bacteria	bacteria	NOUN
njb-33	23	3	include	include	VERB
njb-33	23	4	the	the	DET
njb-33	23	5	other	other	ADJ
njb-33	23	6	members	member	NOUN
njb-33	23	7	of	of	ADP
njb-33	23	8	the	the	DET
njb-33	23	9	enterobacteriaceae	enterobacteriaceae	PROPN
njb-33	23	10	,	,	PUNCT
njb-33	23	11	pseudomonas	pseudomonas	PROPN
njb-33	23	12	aeruginosa	aeruginosa	PROPN
njb-33	23	13	,	,	PUNCT
njb-33	23	14	staphylococcus	staphylococcus	PROPN
njb-33	23	15	saprophyticus	saprophyticus	PROPN
njb-33	23	16	,	,	PUNCT
njb-33	23	17	enterococcus	enterococcus	PROPN
njb-33	23	18	spp	spp	PROPN
njb-33	23	19	.	.	PUNCT
njb-33	23	20	etc	etc	X
njb-33	24	1	[	[	PUNCT
njb-33	24	2	2	2	NUM
njb-33	24	3	]	]	PUNCT
njb-33	24	4	.	.	PUNCT
njb-33	25	1	multidrug	multidrug	VERB
njb-33	25	2	resistant	resistant	ADJ
njb-33	25	3	bacteria	bacteria	NOUN
njb-33	25	4	are	be	AUX
njb-33	25	5	defined	define	VERB
njb-33	25	6	as	as	ADP
njb-33	25	7	the	the	DET
njb-33	25	8	bacteria	bacteria	NOUN
njb-33	25	9	which	which	PRON
njb-33	25	10	are	be	AUX
njb-33	25	11	resistant	resistant	ADJ
njb-33	25	12	to	to	ADP
njb-33	25	13	three	three	NUM
njb-33	25	14	or	or	CCONJ
njb-33	25	15	more	more	ADJ
njb-33	25	16	than	than	ADP
njb-33	25	17	three	three	NUM
njb-33	25	18	different	different	ADJ
njb-33	25	19	structural	structural	ADJ
njb-33	25	20	classes	class	NOUN
njb-33	25	21	of	of	ADP
njb-33	25	22	the	the	DET
njb-33	25	23	antibiotics	antibiotic	NOUN
njb-33	25	24	[	[	PUNCT
njb-33	25	25	3	3	NUM
njb-33	25	26	]	]	PUNCT
njb-33	25	27	.	.	PUNCT
njb-33	26	1	the	the	DET
njb-33	26	2	involvement	involvement	NOUN
njb-33	26	3	of	of	ADP
njb-33	26	4	multi	multi	ADJ
njb-33	26	5	drug	drug	NOUN
njb-33	26	6	resistant	resistant	ADJ
njb-33	26	7	bacteria	bacteria	NOUN
njb-33	26	8	in	in	ADP
njb-33	26	9	causing	cause	VERB
njb-33	26	10	uti	uti	PROPN
njb-33	26	11	has	have	AUX
njb-33	26	12	created	create	VERB
njb-33	26	13	a	a	DET
njb-33	26	14	serious	serious	ADJ
njb-33	26	15	problem	problem	NOUN
njb-33	26	16	for	for	ADP
njb-33	26	17	its	its	PRON
njb-33	26	18	early	early	ADJ
njb-33	26	19	proper	proper	ADJ
njb-33	26	20	management	management	NOUN
njb-33	26	21	.	.	PUNCT
njb-33	27	1	for	for	SCONJ
njb-33	27	2	the	the	DET
njb-33	27	3	proper	proper	ADJ
njb-33	27	4	management	management	NOUN
njb-33	27	5	of	of	ADP
njb-33	27	6	the	the	DET
njb-33	27	7	infections	infection	NOUN
njb-33	27	8	hence	hence	ADV
njb-33	27	9	to	to	PART
njb-33	27	10	prevent	prevent	VERB
njb-33	27	11	the	the	DET
njb-33	27	12	possible	possible	ADJ
njb-33	27	13	complications	complication	NOUN
njb-33	27	14	like	like	ADP
njb-33	27	15	chronic	chronic	ADJ
njb-33	27	16	pyelonephritis	pyelonephritis	NOUN
njb-33	27	17	,	,	PUNCT
njb-33	27	18	chronic	chronic	ADJ
njb-33	27	19	renal	renal	ADJ
njb-33	27	20	failure	failure	NOUN
njb-33	27	21	;	;	PUNCT
njb-33	27	22	timely	timely	ADV
njb-33	27	23	appropriate	appropriate	ADJ
njb-33	27	24	treatment	treatment	NOUN
njb-33	27	25	as	as	SCONJ
njb-33	27	26	suggested	suggest	VERB
njb-33	27	27	by	by	ADP
njb-33	27	28	urine	urine	NOUN
njb-33	27	29	culture	culture	NOUN
njb-33	27	30	and	and	CCONJ
njb-33	27	31	sensitivity	sensitivity	NOUN
njb-33	27	32	report	report	NOUN
njb-33	27	33	is	be	AUX
njb-33	27	34	essential	essential	ADJ
njb-33	27	35	.	.	PUNCT
njb-33	28	1	but	but	CCONJ
njb-33	28	2	in	in	ADP
njb-33	28	3	most	most	ADJ
njb-33	28	4	of	of	ADP
njb-33	28	5	the	the	DET
njb-33	28	6	part	part	NOUN
njb-33	28	7	of	of	ADP
njb-33	28	8	nepal	nepal	NOUN
njb-33	28	9	including	include	VERB
njb-33	28	10	the	the	DET
njb-33	28	11	farwestern	farwestern	ADJ
njb-33	28	12	region	region	NOUN
njb-33	28	13	the	the	DET
njb-33	28	14	urine	urine	NOUN
njb-33	28	15	culture	culture	NOUN
njb-33	28	16	and	and	CCONJ
njb-33	28	17	sensitivity	sensitivity	NOUN
njb-33	28	18	is	be	AUX
njb-33	28	19	not	not	PART
njb-33	28	20	performed	perform	VERB
njb-33	28	21	due	due	ADP
njb-33	28	22	to	to	ADP
njb-33	28	23	lack	lack	NOUN
njb-33	28	24	of	of	ADP
njb-33	28	25	resources	resource	NOUN
njb-33	28	26	and	and	CCONJ
njb-33	28	27	competent	competent	ADJ
njb-33	28	28	manpower	manpower	NOUN
njb-33	28	29	.	.	PUNCT
njb-33	29	1	studies	study	NOUN
njb-33	29	2	on	on	ADP
njb-33	29	3	the	the	DET
njb-33	29	4	prevalence	prevalence	NOUN
njb-33	29	5	of	of	ADP
njb-33	29	6	uti	uti	PROPN
njb-33	29	7	due	due	ADP
njb-33	29	8	to	to	ADP
njb-33	29	9	multidrug	multidrug	VERB
njb-33	29	10	resistant	resistant	ADJ
njb-33	29	11	bacteria	bacteria	NOUN
njb-33	29	12	have	have	AUX
njb-33	29	13	been	be	AUX
njb-33	29	14	carried	carry	VERB
njb-33	29	15	out	out	ADP
njb-33	29	16	frequently	frequently	ADV
njb-33	29	17	in	in	ADP
njb-33	29	18	different	different	ADJ
njb-33	29	19	parts	part	NOUN
njb-33	29	20	of	of	ADP
njb-33	29	21	nepal	nepal	NOUN
njb-33	29	22	but	but	CCONJ
njb-33	29	23	no	no	DET
njb-33	29	24	such	such	ADJ
njb-33	29	25	studies	study	NOUN
njb-33	29	26	have	have	AUX
njb-33	29	27	been	be	AUX
njb-33	29	28	carried	carry	VERB
njb-33	29	29	out	out	ADP
njb-33	29	30	in	in	ADP
njb-33	29	31	farwestern	farwestern	ADJ
njb-33	29	32	region	region	NOUN
njb-33	29	33	.	.	PUNCT
njb-33	30	1	hence	hence	ADV
njb-33	30	2	the	the	DET
njb-33	30	3	prevalence	prevalence	NOUN
njb-33	30	4	of	of	ADP
njb-33	30	5	uti	uti	PROPN
njb-33	30	6	caused	cause	VERB
njb-33	30	7	due	due	ADJ
njb-33	30	8	to	to	ADP
njb-33	30	9	multidrug	multidrug	VERB
njb-33	30	10	resistant	resistant	ADJ
njb-33	30	11	bacteria	bacteria	NOUN
njb-33	30	12	is	be	AUX
njb-33	30	13	unknown	unknown	ADJ
njb-33	30	14	in	in	ADP
njb-33	30	15	this	this	DET
njb-33	30	16	region	region	NOUN
njb-33	30	17	of	of	ADP
njb-33	30	18	nepal	nepal	NOUN
njb-33	30	19	.	.	PUNCT
njb-33	31	1	further	far	ADV
njb-33	31	2	the	the	DET
njb-33	31	3	antimicrobial	antimicrobial	ADJ
njb-33	31	4	susceptibility	susceptibility	NOUN
njb-33	31	5	patterns	pattern	NOUN
njb-33	31	6	of	of	ADP
njb-33	31	7	different	different	ADJ
njb-33	31	8	bacteria	bacteria	NOUN
njb-33	31	9	for	for	ADP
njb-33	31	10	commonly	commonly	ADV
njb-33	31	11	used	use	VERB
njb-33	31	12	antibiotics	antibiotic	NOUN
njb-33	31	13	are	be	AUX
njb-33	31	14	not	not	PART
njb-33	31	15	also	also	ADV
njb-33	31	16	clear	clear	ADJ
njb-33	31	17	in	in	ADP
njb-33	31	18	this	this	DET
njb-33	31	19	region	region	NOUN
njb-33	31	20	.	.	PUNCT
njb-33	32	1	therefore	therefore	ADV
njb-33	32	2	the	the	DET
njb-33	32	3	suspected	suspect	VERB
njb-33	32	4	patients	patient	NOUN
njb-33	32	5	of	of	ADP
njb-33	32	6	uti	uti	PROPN
njb-33	32	7	are	be	AUX
njb-33	32	8	treated	treat	VERB
njb-33	32	9	just	just	ADV
njb-33	32	10	on	on	ADP
njb-33	32	11	the	the	DET
njb-33	32	12	basis	basis	NOUN
njb-33	32	13	of	of	ADP
njb-33	32	14	guess	guess	NOUN
njb-33	32	15	most	most	ADJ
njb-33	32	16	of	of	ADP
njb-33	32	17	times	time	NOUN
njb-33	32	18	mailto:ndpant1987@gmail.com	mailto:ndpant1987@gmail.com	PROPN
njb-33	32	19	nepal	nepal	PROPN
njb-33	32	20	journal	journal	PROPN
njb-33	32	21	of	of	ADP
njb-33	32	22	biotechnology	biotechnology	NOUN
njb-33	32	23	.	.	PUNCT
njb-33	33	1	d	d	X
njb-33	33	2	e	e	PROPN
njb-33	33	3	c	c	PROPN
njb-33	33	4	.	.	PUNCT
njb-33	34	1	2	2	NUM
njb-33	34	2	0	0	NUM
njb-33	34	3	1	1	NUM
njb-33	34	4	5	5	NUM
njb-33	34	5	vol	vol	NOUN
njb-33	34	6	.	.	PUNCT
njb-33	35	1	3	3	NUM
njb-33	35	2	,	,	PUNCT
njb-33	35	3	no	no	INTJ
njb-33	35	4	.	.	NOUN
njb-33	36	1	1:55	1:55	NUM
njb-33	36	2	-	-	SYM
njb-33	36	3	59	59	NUM
njb-33	36	4	awasthi	awasthi	NOUN
njb-33	36	5	et	et	PROPN
njb-33	36	6	al	al	PROPN
njb-33	36	7	.	.	PUNCT
njb-33	37	1	©	©	PROPN
njb-33	37	2	njb	njb	PROPN
njb-33	37	3	,	,	PUNCT
njb-33	37	4	biotechnology	biotechnology	NOUN
njb-33	37	5	society	society	NOUN
njb-33	37	6	of	of	ADP
njb-33	37	7	nepal	nepal	ADJ
njb-33	37	8	56	56	NUM
njb-33	37	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-33	37	10	resulting	result	VERB
njb-33	37	11	in	in	ADP
njb-33	37	12	treatment	treatment	NOUN
njb-33	37	13	failure	failure	NOUN
njb-33	37	14	and	and	CCONJ
njb-33	37	15	development	development	NOUN
njb-33	37	16	of	of	ADP
njb-33	37	17	more	more	ADJ
njb-33	37	18	drug	drug	NOUN
njb-33	37	19	resistance	resistance	NOUN
njb-33	37	20	among	among	ADP
njb-33	37	21	the	the	DET
njb-33	37	22	bacteria	bacteria	NOUN
njb-33	37	23	.	.	PUNCT
njb-33	38	1	hence	hence	ADV
njb-33	38	2	this	this	DET
njb-33	38	3	study	study	NOUN
njb-33	38	4	will	will	AUX
njb-33	38	5	present	present	VERB
njb-33	38	6	the	the	DET
njb-33	38	7	clear	clear	ADJ
njb-33	38	8	picture	picture	NOUN
njb-33	38	9	of	of	ADP
njb-33	38	10	antimicrobial	antimicrobial	ADJ
njb-33	38	11	susceptibility	susceptibility	NOUN
njb-33	38	12	patterns	pattern	NOUN
njb-33	38	13	of	of	ADP
njb-33	38	14	different	different	ADJ
njb-33	38	15	bacteria	bacteria	NOUN
njb-33	38	16	for	for	ADP
njb-33	38	17	commonly	commonly	ADV
njb-33	38	18	used	use	VERB
njb-33	38	19	antibiotics	antibiotic	NOUN
njb-33	38	20	and	and	CCONJ
njb-33	38	21	the	the	DET
njb-33	38	22	involvement	involvement	NOUN
njb-33	38	23	of	of	ADP
njb-33	38	24	the	the	DET
njb-33	38	25	multidrug	multidrug	NOUN
njb-33	38	26	resistant	resistant	ADJ
njb-33	38	27	bacteria	bacteria	NOUN
njb-33	38	28	in	in	ADP
njb-33	38	29	causing	cause	VERB
njb-33	38	30	uti	uti	PROPN
njb-33	38	31	in	in	ADP
njb-33	38	32	far	far	ADJ
njb-33	38	33	western	western	ADJ
njb-33	38	34	region	region	NOUN
njb-33	38	35	of	of	ADP
njb-33	38	36	nepal	nepal	NOUN
njb-33	38	37	.	.	PUNCT
njb-33	39	1	seti	seti	PROPN
njb-33	39	2	zonal	zonal	ADJ
njb-33	39	3	hospital	hospital	NOUN
njb-33	39	4	is	be	AUX
njb-33	39	5	the	the	DET
njb-33	39	6	referral	referral	ADJ
njb-33	39	7	center	center	NOUN
njb-33	39	8	for	for	ADP
njb-33	39	9	whole	whole	ADJ
njb-33	39	10	farwestern	farwestern	ADJ
njb-33	39	11	region	region	NOUN
njb-33	39	12	.	.	PUNCT
njb-33	40	1	antimicrobial	antimicrobial	ADJ
njb-33	40	2	susceptibility	susceptibility	NOUN
njb-33	40	3	pattern	pattern	NOUN
njb-33	40	4	of	of	ADP
njb-33	40	5	the	the	DET
njb-33	40	6	bacteria	bacteria	NOUN
njb-33	40	7	isolated	isolate	VERB
njb-33	40	8	from	from	ADP
njb-33	40	9	the	the	DET
njb-33	40	10	patients	patient	NOUN
njb-33	40	11	(	(	PUNCT
njb-33	40	12	having	have	VERB
njb-33	40	13	no	no	DET
njb-33	40	14	past	past	ADJ
njb-33	40	15	history	history	NOUN
njb-33	40	16	of	of	ADP
njb-33	40	17	hospitalization	hospitalization	NOUN
njb-33	40	18	)	)	PUNCT
njb-33	40	19	with	with	ADP
njb-33	40	20	uti	uti	PROPN
njb-33	40	21	attending	attend	VERB
njb-33	40	22	the	the	DET
njb-33	40	23	outpatient	outpatient	NOUN
njb-33	40	24	department	department	NOUN
njb-33	40	25	of	of	ADP
njb-33	40	26	seti	seti	PROPN
njb-33	40	27	zonal	zonal	ADJ
njb-33	40	28	hospital	hospital	NOUN
njb-33	40	29	was	be	AUX
njb-33	40	30	determined	determined	ADJ
njb-33	40	31	and	and	CCONJ
njb-33	40	32	prevalence	prevalence	NOUN
njb-33	40	33	of	of	ADP
njb-33	40	34	uti	uti	PROPN
njb-33	40	35	due	due	ADP
njb-33	40	36	to	to	ADP
njb-33	40	37	multidrug	multidrug	VERB
njb-33	40	38	resistant	resistant	ADJ
njb-33	40	39	bacteria	bacteria	NOUN
njb-33	40	40	was	be	AUX
njb-33	40	41	calculated	calculate	VERB
njb-33	40	42	.	.	PUNCT
njb-33	41	1	materials	material	NOUN
njb-33	41	2	and	and	CCONJ
njb-33	41	3	methods	method	NOUN
njb-33	41	4	a	a	DET
njb-33	41	5	cross	cross	NOUN
njb-33	41	6	sectional	sectional	ADJ
njb-33	41	7	study	study	NOUN
njb-33	41	8	was	be	AUX
njb-33	41	9	conducted	conduct	VERB
njb-33	41	10	among	among	ADP
njb-33	41	11	the	the	DET
njb-33	41	12	patients	patient	NOUN
njb-33	41	13	suspected	suspect	VERB
njb-33	41	14	of	of	ADP
njb-33	41	15	urinary	urinary	ADJ
njb-33	41	16	tract	tract	NOUN
njb-33	41	17	infection	infection	NOUN
njb-33	41	18	visiting	visit	VERB
njb-33	41	19	outpatient	outpatient	NOUN
njb-33	41	20	department	department	NOUN
njb-33	41	21	of	of	ADP
njb-33	41	22	seti	seti	PROPN
njb-33	41	23	zonal	zonal	ADJ
njb-33	41	24	hospital	hospital	NOUN
njb-33	41	25	from	from	ADP
njb-33	41	26	june	june	PROPN
njb-33	41	27	2013	2013	NUM
njb-33	41	28	to	to	ADP
njb-33	41	29	december	december	PROPN
njb-33	41	30	2013	2013	NUM
njb-33	41	31	.	.	PUNCT
njb-33	42	1	the	the	DET
njb-33	42	2	samples	sample	NOUN
njb-33	42	3	were	be	AUX
njb-33	42	4	collected	collect	VERB
njb-33	42	5	from	from	ADP
njb-33	42	6	only	only	ADV
njb-33	42	7	those	those	DET
njb-33	42	8	patients	patient	NOUN
njb-33	42	9	who	who	PRON
njb-33	42	10	do	do	AUX
njb-33	42	11	not	not	PART
njb-33	42	12	have	have	VERB
njb-33	42	13	past	past	ADJ
njb-33	42	14	history	history	NOUN
njb-33	42	15	of	of	ADP
njb-33	42	16	hospitalization	hospitalization	NOUN
njb-33	42	17	.	.	PUNCT
njb-33	43	1	total	total	ADJ
njb-33	43	2	384	384	NUM
njb-33	43	3	midstream	midstream	NOUN
njb-33	43	4	urine	urine	NOUN
njb-33	43	5	specimens	specimen	NOUN
njb-33	43	6	collected	collect	VERB
njb-33	43	7	aseptically	aseptically	ADV
njb-33	43	8	were	be	AUX
njb-33	43	9	cultured	cultured	ADJ
njb-33	43	10	on	on	ADP
njb-33	43	11	cystine	cystine	ADJ
njb-33	43	12	lactose	lactose	NOUN
njb-33	43	13	electrolyte	electrolyte	NOUN
njb-33	43	14	deficient	deficient	NOUN
njb-33	43	15	(	(	PUNCT
njb-33	43	16	cled	cle	VERB
njb-33	43	17	)	)	PUNCT
njb-33	43	18	agar	agar	NOUN
njb-33	43	19	by	by	ADP
njb-33	43	20	using	use	VERB
njb-33	43	21	semi	semi	ADJ
njb-33	43	22	-	-	ADJ
njb-33	43	23	quantitative	quantitative	ADJ
njb-33	43	24	culture	culture	NOUN
njb-33	43	25	technique	technique	NOUN
njb-33	43	26	.	.	PUNCT
njb-33	44	1	the	the	DET
njb-33	44	2	colonies	colony	NOUN
njb-33	44	3	of	of	ADP
njb-33	44	4	the	the	DET
njb-33	44	5	bacteria	bacteria	NOUN
njb-33	44	6	from	from	ADP
njb-33	44	7	the	the	DET
njb-33	44	8	samples	sample	NOUN
njb-33	44	9	with	with	ADP
njb-33	44	10	significant	significant	ADJ
njb-33	44	11	growth	growth	NOUN
njb-33	44	12	(	(	PUNCT
njb-33	44	13	≥105cfu	≥105cfu	NUM
njb-33	44	14	/	/	SYM
njb-33	44	15	ml	ml	PROPN
njb-33	44	16	)	)	PUNCT
njb-33	44	17	after	after	ADP
njb-33	44	18	48	48	NUM
njb-33	44	19	hrs	hr	NOUN
njb-33	44	20	of	of	ADP
njb-33	44	21	aerobic	aerobic	ADJ
njb-33	44	22	incubation	incubation	NOUN
njb-33	44	23	at	at	ADP
njb-33	44	24	37o	37o	NOUN
njb-33	44	25	c	c	PROPN
njb-33	44	26	were	be	AUX
njb-33	44	27	isolated	isolate	VERB
njb-33	44	28	and	and	CCONJ
njb-33	44	29	were	be	AUX
njb-33	44	30	identified	identify	VERB
njb-33	44	31	up	up	ADP
njb-33	44	32	to	to	ADP
njb-33	44	33	species	species	NOUN
njb-33	44	34	level	level	NOUN
njb-33	44	35	with	with	ADP
njb-33	44	36	the	the	DET
njb-33	44	37	help	help	NOUN
njb-33	44	38	of	of	ADP
njb-33	44	39	colony	colony	NOUN
njb-33	44	40	morphology	morphology	NOUN
njb-33	44	41	,	,	PUNCT
njb-33	44	42	staining	stain	VERB
njb-33	44	43	reactions	reaction	NOUN
njb-33	44	44	and	and	CCONJ
njb-33	44	45	conventional	conventional	ADJ
njb-33	44	46	biochemical	biochemical	ADJ
njb-33	44	47	tests	test	NOUN
njb-33	44	48	.	.	PUNCT
njb-33	45	1	the	the	DET
njb-33	45	2	common	common	ADJ
njb-33	45	3	biochemical	biochemical	ADJ
njb-33	45	4	tests	test	NOUN
njb-33	45	5	used	use	VERB
njb-33	45	6	were	be	AUX
njb-33	45	7	oxidase	oxidase	NOUN
njb-33	45	8	test	test	NOUN
njb-33	45	9	,	,	PUNCT
njb-33	45	10	catalase	catalase	NOUN
njb-33	45	11	test	test	NOUN
njb-33	45	12	,	,	PUNCT
njb-33	45	13	urease	urease	NOUN
njb-33	45	14	test	test	NOUN
njb-33	45	15	,	,	PUNCT
njb-33	45	16	sulphide	sulphide	NOUN
njb-33	45	17	indole	indole	NOUN
njb-33	45	18	motility	motility	NOUN
njb-33	45	19	test	test	NOUN
njb-33	45	20	,	,	PUNCT
njb-33	45	21	citrate	citrate	VERB
njb-33	45	22	utilization	utilization	NOUN
njb-33	45	23	test	test	NOUN
njb-33	45	24	,	,	PUNCT
njb-33	45	25	triple	triple	ADJ
njb-33	45	26	sugar	sugar	NOUN
njb-33	45	27	iron	iron	NOUN
njb-33	45	28	test	test	NOUN
njb-33	45	29	,	,	PUNCT
njb-33	45	30	lysine	lysine	NOUN
njb-33	45	31	decarboxylase	decarboxylase	NOUN
njb-33	45	32	test	test	NOUN
njb-33	45	33	,	,	PUNCT
njb-33	45	34	methyl	methyl	NOUN
njb-33	45	35	-	-	PUNCT
njb-33	45	36	red	red	PROPN
njb-33	45	37	voges	voges	PROPN
njb-33	45	38	proskauer	proskauer	PROPN
njb-33	45	39	test	test	PROPN
njb-33	45	40	,	,	PUNCT
njb-33	45	41	coagulase	coagulase	PROPN
njb-33	45	42	test	test	NOUN
njb-33	45	43	etc	etc	X
njb-33	45	44	.	.	X
njb-33	46	1	during	during	ADP
njb-33	46	2	isolation	isolation	NOUN
njb-33	46	3	and	and	CCONJ
njb-33	46	4	identification	identification	NOUN
njb-33	46	5	purity	purity	NOUN
njb-33	46	6	plate	plate	NOUN
njb-33	46	7	culture	culture	NOUN
njb-33	46	8	was	be	AUX
njb-33	46	9	used	use	VERB
njb-33	46	10	for	for	ADP
njb-33	46	11	quality	quality	NOUN
njb-33	46	12	control	control	NOUN
njb-33	46	13	.	.	PUNCT
njb-33	47	1	antimicrobial	antimicrobial	ADJ
njb-33	47	2	susceptibility	susceptibility	NOUN
njb-33	47	3	testing	testing	NOUN
njb-33	47	4	was	be	AUX
njb-33	47	5	performed	perform	VERB
njb-33	47	6	according	accord	VERB
njb-33	47	7	to	to	ADP
njb-33	47	8	the	the	DET
njb-33	47	9	clinical	clinical	ADJ
njb-33	47	10	laboratory	laboratory	PROPN
njb-33	47	11	standard	standard	PROPN
njb-33	47	12	institute	institute	PROPN
njb-33	47	13	(	(	PUNCT
njb-33	47	14	clsi	clsi	PROPN
njb-33	47	15	2013	2013	NUM
njb-33	47	16	)	)	PUNCT
njb-33	47	17	guidelines	guideline	NOUN
njb-33	47	18	by	by	ADP
njb-33	47	19	modified	modify	VERB
njb-33	47	20	kirby	kirby	PROPN
njb-33	47	21	-	-	PUNCT
njb-33	47	22	bauer	bauer	NOUN
njb-33	47	23	disc	disc	NOUN
njb-33	47	24	diffusion	diffusion	NOUN
njb-33	47	25	method	method	NOUN
njb-33	47	26	using	use	VERB
njb-33	47	27	mueller	mueller	PROPN
njb-33	47	28	hinton	hinton	PROPN
njb-33	47	29	agar	agar	PROPN
njb-33	47	30	(	(	PUNCT
njb-33	47	31	mha	mha	NOUN
njb-33	47	32	)	)	PUNCT
njb-33	47	33	.	.	PUNCT
njb-33	48	1	the	the	DET
njb-33	48	2	diameter	diameter	NOUN
njb-33	48	3	of	of	ADP
njb-33	48	4	each	each	DET
njb-33	48	5	zone	zone	NOUN
njb-33	48	6	of	of	ADP
njb-33	48	7	inhibition	inhibition	NOUN
njb-33	48	8	(	(	PUNCT
njb-33	48	9	in	in	ADP
njb-33	48	10	mm	mm	PROPN
njb-33	48	11	)	)	PUNCT
njb-33	48	12	was	be	AUX
njb-33	48	13	measured	measure	VERB
njb-33	48	14	and	and	CCONJ
njb-33	48	15	results	result	NOUN
njb-33	48	16	were	be	AUX
njb-33	48	17	interpreted	interpret	VERB
njb-33	48	18	with	with	ADP
njb-33	48	19	the	the	DET
njb-33	48	20	help	help	NOUN
njb-33	48	21	of	of	ADP
njb-33	48	22	zone	zone	NOUN
njb-33	48	23	size	size	NOUN
njb-33	48	24	interpretive	interpretive	ADJ
njb-33	48	25	chart	chart	NOUN
njb-33	48	26	.	.	PUNCT
njb-33	49	1	control	control	NOUN
njb-33	49	2	strains	strain	VERB
njb-33	49	3	e.	e.	PROPN
njb-33	49	4	coli	coli	PROPN
njb-33	49	5	(	(	PUNCT
njb-33	49	6	atcc	atcc	PROPN
njb-33	49	7	25922	25922	NUM
njb-33	49	8	)	)	PUNCT
njb-33	49	9	and	and	CCONJ
njb-33	49	10	staphylococcus	staphylococcus	PROPN
njb-33	49	11	aureus	aureus	PROPN
njb-33	49	12	(	(	PUNCT
njb-33	49	13	atcc	atcc	PROPN
njb-33	49	14	25923	25923	NUM
njb-33	49	15	)	)	PUNCT
njb-33	49	16	were	be	AUX
njb-33	49	17	used	use	VERB
njb-33	49	18	for	for	ADP
njb-33	49	19	the	the	DET
njb-33	49	20	standardization	standardization	NOUN
njb-33	49	21	of	of	ADP
njb-33	49	22	the	the	DET
njb-33	49	23	antibiotic	antibiotic	ADJ
njb-33	49	24	susceptibility	susceptibility	NOUN
njb-33	49	25	testing	testing	NOUN
njb-33	49	26	.	.	PUNCT
njb-33	50	1	analysis	analysis	NOUN
njb-33	50	2	for	for	ADP
njb-33	50	3	multidrug	multidrug	NOUN
njb-33	50	4	resistant	resistant	ADJ
njb-33	50	5	bacteria	bacteria	NOUN
njb-33	50	6	:	:	PUNCT
njb-33	50	7	based	base	VERB
njb-33	50	8	on	on	ADP
njb-33	50	9	susceptibility	susceptibility	NOUN
njb-33	50	10	patterns	pattern	NOUN
njb-33	50	11	of	of	ADP
njb-33	50	12	isolates	isolate	NOUN
njb-33	50	13	,	,	PUNCT
njb-33	50	14	bacteria	bacteria	NOUN
njb-33	50	15	resistant	resistant	ADJ
njb-33	50	16	to	to	ADP
njb-33	50	17	≥3	≥3	NOUN
njb-33	50	18	classes	class	NOUN
njb-33	50	19	of	of	ADP
njb-33	50	20	antibiotic	antibiotic	NOUN
njb-33	50	21	were	be	AUX
njb-33	50	22	considered	consider	VERB
njb-33	50	23	as	as	ADP
njb-33	50	24	multi	multi	ADJ
njb-33	50	25	drug	drug	NOUN
njb-33	50	26	resistant	resistant	ADJ
njb-33	50	27	(	(	PUNCT
njb-33	50	28	clsi	clsi	NOUN
njb-33	50	29	2013	2013	NUM
njb-33	50	30	)	)	PUNCT
njb-33	50	31	.	.	PUNCT
njb-33	51	1	data	datum	NOUN
njb-33	51	2	analysis	analysis	VERB
njb-33	51	3	the	the	DET
njb-33	51	4	data	datum	NOUN
njb-33	51	5	obtained	obtain	VERB
njb-33	51	6	was	be	AUX
njb-33	51	7	entered	enter	VERB
njb-33	51	8	into	into	ADP
njb-33	51	9	ms	ms	PROPN
njb-33	51	10	excel	excel	PROPN
njb-33	51	11	and	and	CCONJ
njb-33	51	12	analyzed	analyze	VERB
njb-33	51	13	using	use	VERB
njb-33	51	14	spss	spss	PROPN
njb-33	51	15	version	version	NOUN
njb-33	51	16	11.0	11.0	NUM
njb-33	51	17	.	.	PUNCT
njb-33	52	1	p	p	X
njb-33	52	2	-	-	PUNCT
njb-33	52	3	values	value	NOUN
njb-33	52	4	<	<	SYM
njb-33	52	5	0.05	0.05	NUM
njb-33	52	6	were	be	AUX
njb-33	52	7	considered	consider	VERB
njb-33	52	8	statistically	statistically	ADV
njb-33	52	9	significant	significant	ADJ
njb-33	52	10	.	.	PUNCT
njb-33	53	1	results	result	NOUN
njb-33	53	2	out	out	ADP
njb-33	53	3	of	of	ADP
njb-33	53	4	total	total	ADJ
njb-33	53	5	384	384	NUM
njb-33	53	6	midstream	midstream	NOUN
njb-33	53	7	urine	urine	NOUN
njb-33	53	8	samples	sample	NOUN
njb-33	53	9	,	,	PUNCT
njb-33	53	10	98	98	NUM
njb-33	53	11	(	(	PUNCT
njb-33	53	12	25.52	25.52	NUM
njb-33	53	13	%	%	NOUN
njb-33	53	14	)	)	PUNCT
njb-33	53	15	samples	sample	NOUN
njb-33	53	16	showed	show	VERB
njb-33	53	17	significant	significant	ADJ
njb-33	53	18	bacterial	bacterial	ADJ
njb-33	53	19	growth	growth	NOUN
njb-33	53	20	.	.	PUNCT
njb-33	54	1	29/154	29/154	NUM
njb-33	54	2	(	(	PUNCT
njb-33	54	3	18.83	18.83	NUM
njb-33	54	4	%	%	NOUN
njb-33	54	5	)	)	PUNCT
njb-33	54	6	males	male	NOUN
njb-33	54	7	and	and	CCONJ
njb-33	54	8	69/230	69/230	NUM
njb-33	54	9	(	(	PUNCT
njb-33	54	10	30.00	30.00	NUM
njb-33	54	11	%	%	NOUN
njb-33	54	12	)	)	PUNCT
njb-33	54	13	females	female	NOUN
njb-33	54	14	had	have	VERB
njb-33	54	15	significant	significant	ADJ
njb-33	54	16	bacteriuria	bacteriuria	NOUN
njb-33	54	17	.	.	PUNCT
njb-33	55	1	the	the	DET
njb-33	55	2	association	association	NOUN
njb-33	55	3	of	of	ADP
njb-33	55	4	significant	significant	ADJ
njb-33	55	5	bacteriuria	bacteriuria	NOUN
njb-33	55	6	in	in	ADP
njb-33	55	7	male	male	ADJ
njb-33	55	8	and	and	CCONJ
njb-33	55	9	female	female	ADJ
njb-33	55	10	patients	patient	NOUN
njb-33	55	11	was	be	AUX
njb-33	55	12	found	find	VERB
njb-33	55	13	to	to	PART
njb-33	55	14	be	be	AUX
njb-33	55	15	statistically	statistically	ADV
njb-33	55	16	significant	significant	ADJ
njb-33	55	17	(	(	PUNCT
njb-33	55	18	p<0.05	p<0.05	NOUN
njb-33	55	19	)	)	PUNCT
njb-33	55	20	.	.	PUNCT
njb-33	56	1	among	among	ADP
njb-33	56	2	98	98	NUM
njb-33	56	3	significant	significant	ADJ
njb-33	56	4	bacteriuria	bacteriuria	NOUN
njb-33	56	5	cases	case	NOUN
njb-33	56	6	,	,	PUNCT
njb-33	56	7	6	6	NUM
njb-33	56	8	different	different	ADJ
njb-33	56	9	microorganisms	microorganism	NOUN
njb-33	56	10	were	be	AUX
njb-33	56	11	isolated	isolate	VERB
njb-33	56	12	.	.	PUNCT
njb-33	57	1	among	among	ADP
njb-33	57	2	these	these	DET
njb-33	57	3	isolates	isolate	NOUN
njb-33	57	4	,	,	PUNCT
njb-33	57	5	e.	e.	PROPN
njb-33	57	6	coli	coli	PROPN
njb-33	57	7	(	(	PUNCT
njb-33	57	8	53.06	53.06	NUM
njb-33	57	9	%	%	NOUN
njb-33	57	10	)	)	PUNCT
njb-33	57	11	was	be	AUX
njb-33	57	12	found	find	VERB
njb-33	57	13	to	to	PART
njb-33	57	14	be	be	AUX
njb-33	57	15	the	the	DET
njb-33	57	16	most	most	ADV
njb-33	57	17	predominant	predominant	ADJ
njb-33	57	18	organism	organism	NOUN
njb-33	57	19	followed	follow	VERB
njb-33	57	20	by	by	ADP
njb-33	57	21	klebsiella	klebsiella	PROPN
njb-33	57	22	pneumoniae	pneumoniae	NOUN
njb-33	57	23	(	(	PUNCT
njb-33	57	24	21.43	21.43	NUM
njb-33	57	25	%	%	NOUN
njb-33	57	26	)	)	PUNCT
njb-33	57	27	,	,	PUNCT
njb-33	57	28	pseudomonas	pseudomonas	PROPN
njb-33	57	29	aeruginosa	aeruginosa	PROPN
njb-33	57	30	(	(	PUNCT
njb-33	57	31	12.24	12.24	NUM
njb-33	57	32	%	%	NOUN
njb-33	57	33	)	)	PUNCT
njb-33	57	34	,	,	PUNCT
njb-33	57	35	proteus	proteus	NOUN
njb-33	57	36	vulgaris	vulgaris	NOUN
njb-33	57	37	(	(	PUNCT
njb-33	57	38	7.14	7.14	NUM
njb-33	57	39	%	%	NOUN
njb-33	57	40	)	)	PUNCT
njb-33	57	41	,	,	PUNCT
njb-33	57	42	staphylococcus	staphylococcus	NOUN
njb-33	57	43	aureus	aureus	PROPN
njb-33	57	44	(	(	PUNCT
njb-33	57	45	4.08	4.08	NUM
njb-33	57	46	%	%	NOUN
njb-33	57	47	)	)	PUNCT
njb-33	57	48	and	and	CCONJ
njb-33	57	49	proteus	proteus	NOUN
njb-33	57	50	mirabilis	mirabili	NOUN
njb-33	57	51	(	(	PUNCT
njb-33	57	52	2.04	2.04	NUM
njb-33	57	53	%	%	NOUN
njb-33	57	54	)	)	PUNCT
njb-33	57	55	(	(	PUNCT
njb-33	57	56	table	table	NOUN
njb-33	57	57	no.1	no.1	NOUN
njb-33	57	58	)	)	PUNCT
njb-33	57	59	.	.	PUNCT
njb-33	58	1	table	table	NOUN
njb-33	58	2	no.1	no.1	PROPN
njb-33	58	3	:	:	PUNCT
njb-33	58	4	different	different	ADJ
njb-33	58	5	bacteria	bacteria	NOUN
njb-33	58	6	isolated	isolate	VERB
njb-33	58	7	from	from	ADP
njb-33	58	8	urine	urine	NOUN
njb-33	58	9	of	of	ADP
njb-33	58	10	the	the	DET
njb-33	58	11	patients	patient	NOUN
njb-33	58	12	.	.	PUNCT
njb-33	59	1	susceptibility	susceptibility	NOUN
njb-33	59	2	of	of	ADP
njb-33	59	3	gram	gram	ADJ
njb-33	59	4	negative	negative	ADJ
njb-33	59	5	bacteria	bacteria	NOUN
njb-33	59	6	towards	towards	ADP
njb-33	59	7	different	different	ADJ
njb-33	59	8	antibiotics	antibiotic	NOUN
njb-33	59	9	among	among	ADP
njb-33	59	10	the	the	DET
njb-33	59	11	common	common	ADJ
njb-33	59	12	antibiotics	antibiotic	NOUN
njb-33	59	13	used	use	VERB
njb-33	59	14	against	against	ADP
njb-33	59	15	all	all	DET
njb-33	59	16	gram	gram	ADJ
njb-33	59	17	negative	negative	ADJ
njb-33	59	18	bacteria	bacteria	NOUN
njb-33	59	19	,	,	PUNCT
njb-33	59	20	the	the	DET
njb-33	59	21	most	most	ADV
njb-33	59	22	effective	effective	ADJ
njb-33	59	23	antibiotic	antibiotic	NOUN
njb-33	59	24	was	be	AUX
njb-33	59	25	found	find	VERB
njb-33	59	26	to	to	PART
njb-33	59	27	be	be	AUX
njb-33	59	28	gentamicin	gentamicin	VERB
njb-33	59	29	(	(	PUNCT
njb-33	59	30	57.45	57.45	NUM
njb-33	59	31	%	%	NOUN
njb-33	59	32	)	)	PUNCT
njb-33	59	33	followed	follow	VERB
njb-33	59	34	by	by	ADP
njb-33	59	35	ceftriaxone	ceftriaxone	PROPN
njb-33	59	36	(	(	PUNCT
njb-33	59	37	51.06	51.06	NUM
njb-33	59	38	%	%	NOUN
njb-33	59	39	)	)	PUNCT
njb-33	59	40	,	,	PUNCT
njb-33	59	41	nitrofurantoin	nitrofurantoin	NOUN
njb-33	59	42	(	(	PUNCT
njb-33	59	43	45.75	45.75	NUM
njb-33	59	44	%	%	NOUN
njb-33	59	45	)	)	PUNCT
njb-33	59	46	,	,	PUNCT
njb-33	59	47	cotrimoxazole	cotrimoxazole	PROPN
njb-33	59	48	(	(	PUNCT
njb-33	59	49	32.98	32.98	NUM
njb-33	59	50	%	%	NOUN
njb-33	59	51	)	)	PUNCT
njb-33	59	52	,	,	PUNCT
njb-33	59	53	ofloxacin	ofloxacin	NOUN
njb-33	59	54	(	(	PUNCT
njb-33	59	55	29.79	29.79	NUM
njb-33	59	56	%	%	NOUN
njb-33	59	57	)	)	PUNCT
njb-33	59	58	,	,	PUNCT
njb-33	59	59	nalidixic	nalidixic	ADV
njb-33	59	60	acid	acid	NOUN
njb-33	59	61	(	(	PUNCT
njb-33	59	62	15.96	15.96	NUM
njb-33	59	63	%	%	NOUN
njb-33	59	64	)	)	PUNCT
njb-33	59	65	,	,	PUNCT
njb-33	59	66	and	and	CCONJ
njb-33	59	67	ampicillin	ampicillin	NOUN
njb-33	59	68	(	(	PUNCT
njb-33	59	69	5.32	5.32	NUM
njb-33	59	70	%	%	NOUN
njb-33	59	71	)	)	PUNCT
njb-33	59	72	(	(	PUNCT
njb-33	59	73	table	table	NOUN
njb-33	59	74	no	no	NOUN
njb-33	59	75	.	.	NOUN
njb-33	59	76	2	2	NUM
njb-33	59	77	)	)	PUNCT
njb-33	59	78	.	.	PUNCT
njb-33	60	1	name	name	NOUN
njb-33	60	2	of	of	ADP
njb-33	60	3	the	the	DET
njb-33	60	4	bacteria	bacteria	NOUN
njb-33	60	5	numbers	number	NOUN
njb-33	60	6	isolated	isolate	VERB
njb-33	60	7	(	(	PUNCT
njb-33	60	8	%	%	INTJ
njb-33	60	9	)	)	PUNCT
njb-33	60	10	escherichia	escherichia	NOUN
njb-33	60	11	coli	coli	NOUN
njb-33	60	12	52	52	NUM
njb-33	60	13	(	(	PUNCT
njb-33	60	14	53.06	53.06	NUM
njb-33	60	15	%	%	NOUN
njb-33	60	16	)	)	PUNCT
njb-33	60	17	klebsiella	klebsiella	PROPN
njb-33	60	18	pneumoniae	pneumoniae	PROPN
njb-33	60	19	21	21	NUM
njb-33	60	20	(	(	PUNCT
njb-33	60	21	21.43	21.43	NUM
njb-33	60	22	%	%	NOUN
njb-33	60	23	)	)	PUNCT
njb-33	60	24	pseudomonas	pseudomonas	PROPN
njb-33	60	25	aeruginosa	aeruginosa	PROPN
njb-33	60	26	12	12	NUM
njb-33	60	27	(	(	PUNCT
njb-33	60	28	12.24	12.24	NUM
njb-33	60	29	%	%	NOUN
njb-33	60	30	)	)	PUNCT
njb-33	60	31	proteus	proteus	NOUN
njb-33	60	32	vulgaris	vulgaris	NOUN
njb-33	60	33	7	7	NUM
njb-33	60	34	(	(	PUNCT
njb-33	60	35	7.14	7.14	NUM
njb-33	60	36	%	%	NOUN
njb-33	60	37	)	)	PUNCT
njb-33	60	38	staphylococcus	staphylococcus	NOUN
njb-33	60	39	aureus	aureus	PROPN
njb-33	60	40	4(4.08	4(4.08	NUM
njb-33	60	41	%	%	NOUN
njb-33	60	42	)	)	PUNCT
njb-33	60	43	proteus	proteus	NOUN
njb-33	60	44	mirabilis	mirabilis	NOUN
njb-33	60	45	2	2	NUM
njb-33	60	46	(	(	PUNCT
njb-33	60	47	2.04	2.04	NUM
njb-33	60	48	%	%	NOUN
njb-33	60	49	)	)	PUNCT
njb-33	60	50	nepal	nepal	ADJ
njb-33	60	51	journal	journal	NOUN
njb-33	60	52	of	of	ADP
njb-33	60	53	biotechnology	biotechnology	NOUN
njb-33	60	54	.	.	PUNCT
njb-33	61	1	d	d	X
njb-33	61	2	e	e	PROPN
njb-33	61	3	c	c	PROPN
njb-33	61	4	.	.	PUNCT
njb-33	62	1	2	2	NUM
njb-33	62	2	0	0	NUM
njb-33	62	3	1	1	NUM
njb-33	62	4	5	5	NUM
njb-33	62	5	vol	vol	NOUN
njb-33	62	6	.	.	PUNCT
njb-33	63	1	3	3	NUM
njb-33	63	2	,	,	PUNCT
njb-33	63	3	no	no	INTJ
njb-33	63	4	.	.	NOUN
njb-33	64	1	1:55	1:55	NUM
njb-33	64	2	-	-	SYM
njb-33	64	3	59	59	NUM
njb-33	64	4	awasthi	awasthi	NOUN
njb-33	64	5	et	et	PROPN
njb-33	64	6	al	al	PROPN
njb-33	64	7	.	.	PUNCT
njb-33	65	1	©	©	PROPN
njb-33	65	2	njb	njb	PROPN
njb-33	65	3	,	,	PUNCT
njb-33	65	4	biotechnology	biotechnology	NOUN
njb-33	65	5	society	society	NOUN
njb-33	65	6	of	of	ADP
njb-33	65	7	nepal	nepal	ADJ
njb-33	65	8	57	57	NUM
njb-33	65	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-33	65	10	table	table	NOUN
njb-33	65	11	no.2	no.2	PROPN
njb-33	65	12	:	:	PUNCT
njb-33	65	13	susceptibility	susceptibility	NOUN
njb-33	65	14	of	of	ADP
njb-33	65	15	gram	gram	ADJ
njb-33	65	16	negative	negative	ADJ
njb-33	65	17	bacteria	bacteria	NOUN
njb-33	65	18	towards	towards	ADP
njb-33	65	19	different	different	ADJ
njb-33	65	20	commonly	commonly	ADV
njb-33	65	21	used	use	VERB
njb-33	65	22	antibiotics	antibiotic	NOUN
njb-33	65	23	.	.	PUNCT
njb-33	66	1	antibiotics	antibiotic	NOUN
njb-33	66	2	numbers	number	NOUN
njb-33	66	3	of	of	ADP
njb-33	66	4	sensitive	sensitive	ADJ
njb-33	66	5	gram	gram	NOUN
njb-33	66	6	negative	negative	ADJ
njb-33	66	7	bacteria	bacteria	NOUN
njb-33	66	8	(	(	PUNCT
njb-33	66	9	%	%	INTJ
njb-33	66	10	)	)	PUNCT
njb-33	66	11	gentamicin	gentamicin	PROPN
njb-33	66	12	57.45	57.45	NUM
njb-33	66	13	ceftriaxone	ceftriaxone	PROPN
njb-33	66	14	51.06	51.06	NUM
njb-33	66	15	nitrofurantoin	nitrofurantoin	NOUN
njb-33	66	16	45.75	45.75	NUM
njb-33	66	17	co	co	NOUN
njb-33	66	18	-	-	NOUN
njb-33	66	19	trimoxazole	trimoxazole	VERB
njb-33	66	20	32.98	32.98	NUM
njb-33	66	21	ofloxacin	ofloxacin	NOUN
njb-33	66	22	29.79	29.79	NUM
njb-33	66	23	nalidixic	nalidixic	NOUN
njb-33	66	24	acid	acid	NOUN
njb-33	66	25	15.96	15.96	NUM
njb-33	66	26	ampicillin	ampicillin	NOUN
njb-33	66	27	5.32	5.32	NUM
njb-33	66	28	among	among	ADP
njb-33	66	29	the	the	DET
njb-33	66	30	4	4	NUM
njb-33	66	31	gram	gram	NOUN
njb-33	66	32	positive	positive	ADJ
njb-33	66	33	bacteria	bacteria	NOUN
njb-33	66	34	all	all	DET
njb-33	66	35	isolates	isolate	NOUN
njb-33	66	36	were	be	AUX
njb-33	66	37	staphylococcus	staphylococcus	NOUN
njb-33	66	38	aureus	aureus	NOUN
njb-33	66	39	.	.	PUNCT
njb-33	67	1	all	all	PRON
njb-33	67	2	of	of	ADP
njb-33	67	3	them	they	PRON
njb-33	67	4	were	be	AUX
njb-33	67	5	susceptible	susceptible	ADJ
njb-33	67	6	to	to	ADP
njb-33	67	7	gentamicin	gentamicin	PROPN
njb-33	67	8	and	and	CCONJ
njb-33	67	9	3(75.00	3(75.00	NUM
njb-33	67	10	%	%	NOUN
njb-33	67	11	)	)	PUNCT
njb-33	67	12	were	be	AUX
njb-33	67	13	susceptible	susceptible	ADJ
njb-33	67	14	to	to	ADP
njb-33	67	15	ceftriaxone	ceftriaxone	NOUN
njb-33	67	16	.	.	PUNCT
njb-33	68	1	half	half	NOUN
njb-33	68	2	of	of	ADP
njb-33	68	3	the	the	DET
njb-33	68	4	s.	s.	PROPN
njb-33	68	5	aureus	aureus	PROPN
njb-33	68	6	isolates	isolate	NOUN
njb-33	68	7	were	be	AUX
njb-33	68	8	susceptible	susceptible	ADJ
njb-33	68	9	to	to	ADP
njb-33	68	10	ampicillin	ampicillin	NOUN
njb-33	68	11	,	,	PUNCT
njb-33	68	12	co	co	NOUN
njb-33	68	13	-	-	NOUN
njb-33	68	14	trimoxazole	trimoxazole	NOUN
njb-33	68	15	and	and	CCONJ
njb-33	68	16	ofloxacin	ofloxacin	NOUN
njb-33	68	17	each	each	PRON
njb-33	68	18	.	.	PUNCT
njb-33	69	1	1(25.00	1(25.00	NUM
njb-33	69	2	%	%	NOUN
njb-33	69	3	)	)	PUNCT
njb-33	69	4	isolate	isolate	VERB
njb-33	69	5	was	be	AUX
njb-33	69	6	found	find	VERB
njb-33	69	7	to	to	PART
njb-33	69	8	be	be	AUX
njb-33	69	9	susceptible	susceptible	ADJ
njb-33	69	10	to	to	ADP
njb-33	69	11	nalidixic	nalidixic	ADJ
njb-33	69	12	acid	acid	NOUN
njb-33	69	13	and	and	CCONJ
njb-33	69	14	nitrofurantoin	nitrofurantoin	NOUN
njb-33	69	15	each	each	PRON
njb-33	69	16	.	.	PUNCT
njb-33	70	1	multidrug	multidrug	VERB
njb-33	70	2	resistance	resistance	NOUN
njb-33	70	3	among	among	ADP
njb-33	70	4	various	various	ADJ
njb-33	70	5	bacteria	bacteria	NOUN
njb-33	70	6	out	out	ADP
njb-33	70	7	of	of	ADP
njb-33	70	8	98	98	NUM
njb-33	70	9	isolates	isolate	NOUN
njb-33	70	10	,	,	PUNCT
njb-33	70	11	42	42	NUM
njb-33	70	12	(	(	PUNCT
njb-33	70	13	42.86	42.86	NUM
njb-33	70	14	%	%	NOUN
njb-33	70	15	)	)	PUNCT
njb-33	70	16	were	be	AUX
njb-33	70	17	found	find	VERB
njb-33	70	18	to	to	PART
njb-33	70	19	be	be	AUX
njb-33	70	20	mdr	mdr	PROPN
njb-33	70	21	.	.	PUNCT
njb-33	71	1	48.08	48.08	NUM
njb-33	71	2	%	%	NOUN
njb-33	71	3	of	of	ADP
njb-33	71	4	the	the	DET
njb-33	71	5	e.	e.	PROPN
njb-33	71	6	coli	coli	PROPN
njb-33	71	7	,	,	PUNCT
njb-33	71	8	19.05	19.05	NUM
njb-33	71	9	%	%	NOUN
njb-33	71	10	of	of	ADP
njb-33	71	11	the	the	DET
njb-33	71	12	k.	k.	PROPN
njb-33	71	13	pneumonia	pneumonia	NOUN
njb-33	71	14	,	,	PUNCT
njb-33	71	15	50	50	NUM
njb-33	71	16	%	%	NOUN
njb-33	71	17	of	of	ADP
njb-33	71	18	the	the	DET
njb-33	71	19	p.	p.	PROPN
njb-33	71	20	aeruginosa	aeruginosa	PROPN
njb-33	71	21	,	,	PUNCT
njb-33	71	22	85.71	85.71	NUM
njb-33	71	23	%	%	NOUN
njb-33	71	24	of	of	ADP
njb-33	71	25	the	the	DET
njb-33	71	26	p.	p.	NOUN
njb-33	71	27	vulgaris	vulgaris	NOUN
njb-33	71	28	and	and	CCONJ
njb-33	71	29	25	25	NUM
njb-33	71	30	%	%	NOUN
njb-33	71	31	of	of	ADP
njb-33	71	32	the	the	DET
njb-33	71	33	staphylococcus	staphylococcus	NOUN
njb-33	71	34	aureus	aureus	PROPN
njb-33	71	35	were	be	AUX
njb-33	71	36	found	find	VERB
njb-33	71	37	to	to	PART
njb-33	71	38	be	be	AUX
njb-33	71	39	mdr	mdr	PROPN
njb-33	71	40	.	.	PUNCT
njb-33	72	1	no	no	DET
njb-33	72	2	isolates	isolate	NOUN
njb-33	72	3	of	of	ADP
njb-33	72	4	p.	p.	PROPN
njb-33	72	5	mirabilis	mirabilis	PROPN
njb-33	72	6	were	be	AUX
njb-33	72	7	mdr	mdr	PROPN
njb-33	72	8	(	(	PUNCT
njb-33	72	9	table	table	NOUN
njb-33	72	10	no	no	NOUN
njb-33	72	11	.	.	NOUN
njb-33	72	12	3	3	NUM
njb-33	72	13	)	)	PUNCT
njb-33	72	14	.	.	PUNCT
njb-33	73	1	table	table	NOUN
njb-33	73	2	no.3	no.3	PROPN
njb-33	73	3	:	:	PUNCT
njb-33	74	1	multidrug	multidrug	VERB
njb-33	74	2	resistance	resistance	NOUN
njb-33	74	3	among	among	ADP
njb-33	74	4	different	different	ADJ
njb-33	74	5	bacteria	bacteria	NOUN
njb-33	74	6	.	.	PUNCT
njb-33	75	1	name	name	NOUN
njb-33	75	2	of	of	ADP
njb-33	75	3	bacteria	bacteria	NOUN
njb-33	75	4	number	number	NOUN
njb-33	75	5	of	of	ADP
njb-33	75	6	multi	multi	ADJ
njb-33	75	7	drug	drug	NOUN
njb-33	75	8	resistant	resistant	ADJ
njb-33	75	9	bacteria	bacteria	NOUN
njb-33	75	10	(	(	PUNCT
njb-33	75	11	%	%	NOUN
njb-33	75	12	)	)	PUNCT
njb-33	75	13	escherichia	escherichia	NOUN
njb-33	75	14	coli	coli	NOUN
njb-33	75	15	48.08	48.08	NUM
njb-33	75	16	klebsiella	klebsiella	PROPN
njb-33	75	17	pneumoniae	pneumoniae	NOUN
njb-33	75	18	19.05	19.05	NUM
njb-33	75	19	pseudomonas	pseudomonas	PROPN
njb-33	75	20	aeruginosa	aeruginosa	PROPN
njb-33	75	21	50	50	NUM
njb-33	75	22	proteus	proteus	NOUN
njb-33	75	23	vulgaris	vulgaris	NOUN
njb-33	75	24	85.71	85.71	NUM
njb-33	75	25	staphylococcus	staphylococcus	PROPN
njb-33	75	26	aureus	aureus	PROPN
njb-33	75	27	25	25	NUM
njb-33	75	28	proteus	proteus	NOUN
njb-33	75	29	mirabilis	mirabili	NOUN
njb-33	75	30	0	0	NUM
njb-33	75	31	discussion	discussion	NOUN
njb-33	75	32	out	out	ADP
njb-33	75	33	of	of	ADP
njb-33	75	34	total	total	ADJ
njb-33	75	35	384	384	NUM
njb-33	75	36	urine	urine	NOUN
njb-33	75	37	samples	sample	NOUN
njb-33	75	38	98	98	NUM
njb-33	75	39	(	(	PUNCT
njb-33	75	40	25.52	25.52	NUM
njb-33	75	41	%	%	NOUN
njb-33	75	42	)	)	PUNCT
njb-33	75	43	samples	sample	NOUN
njb-33	75	44	showed	show	VERB
njb-33	75	45	significant	significant	ADJ
njb-33	75	46	growth	growth	NOUN
njb-33	75	47	.	.	PUNCT
njb-33	76	1	similar	similar	ADJ
njb-33	76	2	type	type	NOUN
njb-33	76	3	of	of	ADP
njb-33	76	4	result	result	NOUN
njb-33	76	5	was	be	AUX
njb-33	76	6	obtained	obtain	VERB
njb-33	76	7	by	by	ADP
njb-33	76	8	sharma	sharma	PROPN
njb-33	76	9	et	et	PROPN
njb-33	76	10	al	al	PROPN
njb-33	76	11	(	(	PUNCT
njb-33	76	12	27.3	27.3	NUM
njb-33	76	13	%	%	NOUN
njb-33	76	14	)	)	PUNCT
njb-33	77	1	[	[	X
njb-33	77	2	4	4	NUM
njb-33	77	3	]	]	X
njb-33	77	4	.	.	PUNCT
njb-33	78	1	females	female	NOUN
njb-33	78	2	are	be	AUX
njb-33	78	3	more	more	ADV
njb-33	78	4	prone	prone	ADJ
njb-33	78	5	to	to	ADP
njb-33	78	6	uti	uti	PROPN
njb-33	78	7	than	than	ADP
njb-33	78	8	males	male	NOUN
njb-33	78	9	.	.	PUNCT
njb-33	79	1	in	in	ADP
njb-33	79	2	the	the	DET
njb-33	79	3	present	present	ADJ
njb-33	79	4	study	study	NOUN
njb-33	79	5	also	also	ADV
njb-33	79	6	,	,	PUNCT
njb-33	79	7	same	same	ADJ
njb-33	79	8	fact	fact	NOUN
njb-33	79	9	was	be	AUX
njb-33	79	10	observed	observe	VERB
njb-33	79	11	where	where	SCONJ
njb-33	79	12	the	the	DET
njb-33	79	13	rate	rate	NOUN
njb-33	79	14	of	of	ADP
njb-33	79	15	growth	growth	NOUN
njb-33	79	16	positivity	positivity	NOUN
njb-33	79	17	was	be	AUX
njb-33	79	18	found	find	VERB
njb-33	79	19	to	to	PART
njb-33	79	20	be	be	AUX
njb-33	79	21	30.00	30.00	NUM
njb-33	79	22	%	%	NOUN
njb-33	79	23	(	(	PUNCT
njb-33	79	24	69/230	69/230	NUM
njb-33	79	25	)	)	PUNCT
njb-33	79	26	in	in	ADP
njb-33	79	27	females	female	NOUN
njb-33	79	28	and	and	CCONJ
njb-33	79	29	18.83	18.83	NUM
njb-33	79	30	%	%	NOUN
njb-33	79	31	(	(	PUNCT
njb-33	79	32	29/154	29/154	NUM
njb-33	79	33	)	)	PUNCT
njb-33	79	34	in	in	ADP
njb-33	79	35	males	male	NOUN
njb-33	79	36	.	.	PUNCT
njb-33	80	1	our	our	PRON
njb-33	80	2	findings	finding	NOUN
njb-33	80	3	were	be	AUX
njb-33	80	4	consistent	consistent	ADJ
njb-33	80	5	with	with	ADP
njb-33	80	6	the	the	DET
njb-33	80	7	findings	finding	NOUN
njb-33	80	8	by	by	ADP
njb-33	80	9	shrestha	shrestha	PROPN
njb-33	80	10	et	et	X
njb-33	80	11	al	al	PROPN
njb-33	80	12	[	[	PUNCT
njb-33	80	13	5	5	NUM
njb-33	80	14	]	]	PUNCT
njb-33	80	15	who	who	PRON
njb-33	80	16	reported	report	VERB
njb-33	80	17	the	the	DET
njb-33	80	18	culture	culture	NOUN
njb-33	80	19	positivity	positivity	NOUN
njb-33	80	20	of	of	ADP
njb-33	80	21	29.8	29.8	NUM
njb-33	80	22	%	%	NOUN
njb-33	80	23	in	in	ADP
njb-33	80	24	females	female	NOUN
njb-33	80	25	and	and	CCONJ
njb-33	80	26	15.2	15.2	NUM
njb-33	80	27	%	%	NOUN
njb-33	80	28	in	in	ADP
njb-33	80	29	males	male	NOUN
njb-33	80	30	.	.	PUNCT
njb-33	81	1	in	in	ADP
njb-33	81	2	a	a	DET
njb-33	81	3	similar	similar	ADJ
njb-33	81	4	study	study	NOUN
njb-33	81	5	by	by	ADP
njb-33	81	6	baral	baral	ADJ
njb-33	81	7	et	et	PROPN
njb-33	81	8	al	al	PROPN
njb-33	81	9	.	.	PUNCT
njb-33	82	1	[	[	X
njb-33	82	2	6	6	NUM
njb-33	82	3	]	]	PUNCT
njb-33	82	4	the	the	DET
njb-33	82	5	growth	growth	NOUN
njb-33	82	6	positivity	positivity	NOUN
njb-33	82	7	was	be	AUX
njb-33	82	8	33.5	33.5	NUM
njb-33	82	9	%	%	NOUN
njb-33	82	10	among	among	ADP
njb-33	82	11	female	female	ADJ
njb-33	82	12	patients	patient	NOUN
njb-33	82	13	and	and	CCONJ
njb-33	82	14	23.7	23.7	NUM
njb-33	82	15	%	%	NOUN
njb-33	82	16	,	,	PUNCT
njb-33	82	17	in	in	ADP
njb-33	82	18	male	male	ADJ
njb-33	82	19	patients	patient	NOUN
njb-33	82	20	.	.	PUNCT
njb-33	83	1	this	this	DET
njb-33	83	2	higher	high	ADJ
njb-33	83	3	growth	growth	NOUN
njb-33	83	4	positivity	positivity	NOUN
njb-33	83	5	seen	see	VERB
njb-33	83	6	in	in	ADP
njb-33	83	7	females	female	NOUN
njb-33	83	8	was	be	AUX
njb-33	83	9	found	find	VERB
njb-33	83	10	to	to	PART
njb-33	83	11	be	be	AUX
njb-33	83	12	statistically	statistically	ADV
njb-33	83	13	significant	significant	ADJ
njb-33	83	14	(	(	PUNCT
njb-33	83	15	p<0.05	p<0.05	NOUN
njb-33	83	16	)	)	PUNCT
njb-33	83	17	and	and	CCONJ
njb-33	83	18	is	be	AUX
njb-33	83	19	due	due	ADJ
njb-33	83	20	to	to	ADP
njb-33	83	21	their	their	PRON
njb-33	83	22	anatomical	anatomical	ADJ
njb-33	83	23	structure	structure	NOUN
njb-33	83	24	(	(	PUNCT
njb-33	83	25	short	short	ADJ
njb-33	83	26	urethra	urethra	NOUN
njb-33	83	27	and	and	CCONJ
njb-33	83	28	proximity	proximity	NOUN
njb-33	83	29	to	to	ADP
njb-33	83	30	anal	anal	ADJ
njb-33	83	31	orifice	orifice	NOUN
njb-33	83	32	)	)	PUNCT
njb-33	83	33	leading	lead	VERB
njb-33	83	34	to	to	ADP
njb-33	83	35	easy	easy	ADJ
njb-33	83	36	access	access	NOUN
njb-33	83	37	for	for	ADP
njb-33	83	38	enteric	enteric	ADJ
njb-33	83	39	bacteria	bacteria	NOUN
njb-33	83	40	.	.	PUNCT
njb-33	84	1	among	among	ADP
njb-33	84	2	the	the	DET
njb-33	84	3	total	total	ADJ
njb-33	84	4	98	98	NUM
njb-33	84	5	bacterial	bacterial	ADJ
njb-33	84	6	isolates	isolate	NOUN
njb-33	84	7	,	,	PUNCT
njb-33	84	8	94(95.92	94(95.92	NUM
njb-33	84	9	%	%	NOUN
njb-33	84	10	)	)	PUNCT
njb-33	84	11	were	be	AUX
njb-33	84	12	gram	gram	NOUN
njb-33	84	13	negative	negative	ADJ
njb-33	84	14	bacilli	bacilli	NOUN
njb-33	84	15	and	and	CCONJ
njb-33	84	16	only	only	ADV
njb-33	84	17	4	4	NUM
njb-33	84	18	(	(	PUNCT
njb-33	84	19	4.08	4.08	NUM
njb-33	84	20	%	%	NOUN
njb-33	84	21	)	)	PUNCT
njb-33	84	22	were	be	AUX
njb-33	84	23	found	find	VERB
njb-33	84	24	to	to	PART
njb-33	84	25	be	be	AUX
njb-33	84	26	gram	gram	ADJ
njb-33	84	27	positive	positive	ADJ
njb-33	84	28	cocci	cocci	NOUN
njb-33	84	29	.	.	PUNCT
njb-33	85	1	the	the	DET
njb-33	85	2	results	result	NOUN
njb-33	85	3	were	be	AUX
njb-33	85	4	in	in	ADP
njb-33	85	5	the	the	DET
njb-33	85	6	favor	favor	NOUN
njb-33	85	7	of	of	ADP
njb-33	85	8	the	the	DET
njb-33	85	9	findings	finding	NOUN
njb-33	85	10	of	of	ADP
njb-33	85	11	shrestha	shrestha	X
njb-33	85	12	et	et	X
njb-33	85	13	al	al	PROPN
njb-33	85	14	[	[	PUNCT
njb-33	85	15	5	5	NUM
njb-33	85	16	]	]	PUNCT
njb-33	85	17	and	and	CCONJ
njb-33	85	18	karki	karki	PROPN
njb-33	85	19	et	et	PROPN
njb-33	85	20	al	al	PROPN
njb-33	86	1	[	[	PUNCT
njb-33	86	2	7	7	NUM
njb-33	86	3	]	]	PUNCT
njb-33	86	4	.	.	PUNCT
njb-33	87	1	in	in	ADP
njb-33	87	2	the	the	DET
njb-33	87	3	study	study	NOUN
njb-33	87	4	by	by	ADP
njb-33	87	5	shrestha	shrestha	PROPN
njb-33	87	6	et	et	X
njb-33	87	7	al	al	PROPN
njb-33	87	8	[	[	PUNCT
njb-33	87	9	5	5	NUM
njb-33	87	10	]	]	PUNCT
njb-33	87	11	among	among	ADP
njb-33	87	12	the	the	DET
njb-33	87	13	total	total	ADJ
njb-33	87	14	80	80	NUM
njb-33	87	15	bacterial	bacterial	ADJ
njb-33	87	16	isolates	isolate	NOUN
njb-33	87	17	,	,	PUNCT
njb-33	87	18	75	75	NUM
njb-33	87	19	(	(	PUNCT
njb-33	87	20	93.8	93.8	NUM
njb-33	87	21	%	%	NOUN
njb-33	87	22	)	)	PUNCT
njb-33	87	23	were	be	AUX
njb-33	87	24	gram	gram	NOUN
njb-33	87	25	negative	negative	ADJ
njb-33	87	26	bacilli	bacilli	NOUN
njb-33	87	27	and	and	CCONJ
njb-33	87	28	only	only	ADV
njb-33	87	29	5	5	NUM
njb-33	87	30	(	(	PUNCT
njb-33	87	31	6.3	6.3	NUM
njb-33	87	32	%	%	NOUN
njb-33	87	33	)	)	PUNCT
njb-33	87	34	were	be	AUX
njb-33	87	35	gram	gram	PROPN
njb-33	87	36	positive	positive	ADJ
njb-33	87	37	cocci	cocci	NOUN
njb-33	87	38	.	.	PUNCT
njb-33	88	1	similarly	similarly	ADV
njb-33	88	2	karki	karki	PROPN
njb-33	88	3	et	et	PROPN
njb-33	88	4	al	al	PROPN
njb-33	89	1	[	[	PUNCT
njb-33	89	2	7	7	NUM
njb-33	89	3	]	]	PUNCT
njb-33	89	4	found	find	VERB
njb-33	89	5	91.1	91.1	NUM
njb-33	89	6	%	%	NOUN
njb-33	89	7	of	of	ADP
njb-33	89	8	the	the	DET
njb-33	89	9	isolates	isolate	NOUN
njb-33	89	10	from	from	ADP
njb-33	89	11	urine	urine	NOUN
njb-33	89	12	to	to	PART
njb-33	89	13	be	be	AUX
njb-33	89	14	gram	gram	ADJ
njb-33	89	15	negative	negative	ADJ
njb-33	89	16	bacilli	bacilli	NOUN
njb-33	89	17	and	and	CCONJ
njb-33	89	18	8.8	8.8	NUM
njb-33	89	19	%	%	NOUN
njb-33	89	20	of	of	ADP
njb-33	89	21	them	they	PRON
njb-33	89	22	to	to	PART
njb-33	89	23	be	be	AUX
njb-33	89	24	gram	gram	ADJ
njb-33	89	25	positive	positive	ADJ
njb-33	89	26	cocci	cocci	NOUN
njb-33	89	27	.	.	PUNCT
njb-33	90	1	among	among	ADP
njb-33	90	2	98	98	NUM
njb-33	90	3	significant	significant	ADJ
njb-33	90	4	bacteriuria	bacteriuria	NOUN
njb-33	90	5	cases	case	NOUN
njb-33	90	6	,	,	PUNCT
njb-33	90	7	6	6	NUM
njb-33	90	8	different	different	ADJ
njb-33	90	9	species	specie	NOUN
njb-33	90	10	of	of	ADP
njb-33	90	11	the	the	DET
njb-33	90	12	bacteria	bacteria	NOUN
njb-33	90	13	were	be	AUX
njb-33	90	14	isolated	isolate	VERB
njb-33	90	15	.	.	PUNCT
njb-33	91	1	among	among	ADP
njb-33	91	2	these	these	DET
njb-33	91	3	isolates	isolate	NOUN
njb-33	91	4	,	,	PUNCT
njb-33	91	5	e.	e.	PROPN
njb-33	91	6	coli	coli	PROPN
njb-33	91	7	52	52	NUM
njb-33	91	8	(	(	PUNCT
njb-33	91	9	53.06	53.06	NUM
njb-33	91	10	%	%	NOUN
njb-33	91	11	)	)	PUNCT
njb-33	91	12	was	be	AUX
njb-33	91	13	found	find	VERB
njb-33	91	14	to	to	PART
njb-33	91	15	be	be	AUX
njb-33	91	16	the	the	DET
njb-33	91	17	most	most	ADV
njb-33	91	18	predominant	predominant	ADJ
njb-33	91	19	organism	organism	NOUN
njb-33	91	20	followed	follow	VERB
njb-33	91	21	by	by	ADP
njb-33	91	22	klebsiella	klebsiella	PROPN
njb-33	91	23	pneumoniae	pneumoniae	PROPN
njb-33	91	24	21(21.43	21(21.43	NUM
njb-33	91	25	%	%	NOUN
njb-33	91	26	)	)	PUNCT
njb-33	91	27	,	,	PUNCT
njb-33	91	28	pseudomonas	pseudomonas	PROPN
njb-33	91	29	aeruginosa	aeruginosa	PROPN
njb-33	91	30	12(12.24	12(12.24	NUM
njb-33	91	31	%	%	NOUN
njb-33	91	32	)	)	PUNCT
njb-33	91	33	,	,	PUNCT
njb-33	91	34	proteus	proteus	NOUN
njb-33	91	35	vulgaris	vulgaris	NOUN
njb-33	91	36	7(7.14	7(7.14	NUM
njb-33	91	37	%	%	NOUN
njb-33	91	38	)	)	PUNCT
njb-33	91	39	,	,	PUNCT
njb-33	91	40	staphylococcus	staphylococcus	NOUN
njb-33	91	41	aureus	aureus	PROPN
njb-33	91	42	4(4.08	4(4.08	NUM
njb-33	91	43	%	%	NOUN
njb-33	91	44	)	)	PUNCT
njb-33	91	45	and	and	CCONJ
njb-33	91	46	proteus	proteus	NOUN
njb-33	91	47	mirabilis	mirabilis	PROPN
njb-33	91	48	2(2.04	2(2.04	NUM
njb-33	91	49	%	%	NOUN
njb-33	91	50	)	)	PUNCT
njb-33	91	51	.	.	PUNCT
njb-33	92	1	in	in	ADP
njb-33	92	2	a	a	DET
njb-33	92	3	similar	similar	ADJ
njb-33	92	4	study	study	NOUN
njb-33	92	5	done	do	VERB
njb-33	92	6	by	by	ADP
njb-33	92	7	khanal	khanal	ADJ
njb-33	92	8	et	et	PROPN
njb-33	92	9	al	al	PROPN
njb-33	92	10	,	,	PUNCT
njb-33	92	11	out	out	ADP
njb-33	92	12	of	of	ADP
njb-33	92	13	41	41	NUM
njb-33	92	14	isolates	isolate	NOUN
njb-33	92	15	isolated	isolate	VERB
njb-33	92	16	from	from	ADP
njb-33	92	17	mid	mid	ADJ
njb-33	92	18	stream	stream	NOUN
njb-33	92	19	urine	urine	NOUN
njb-33	92	20	samples	sample	NOUN
njb-33	92	21	8	8	NUM
njb-33	92	22	different	different	ADJ
njb-33	92	23	species	specie	NOUN
njb-33	92	24	were	be	AUX
njb-33	92	25	isolated	isolate	VERB
njb-33	92	26	among	among	ADP
njb-33	92	27	which	which	PRON
njb-33	92	28	e.	e.	PROPN
njb-33	92	29	coli	coli	PROPN
njb-33	92	30	(	(	PUNCT
njb-33	92	31	65.85	65.85	NUM
njb-33	92	32	%	%	NOUN
njb-33	92	33	)	)	PUNCT
njb-33	92	34	was	be	AUX
njb-33	92	35	found	find	VERB
njb-33	92	36	to	to	PART
njb-33	92	37	be	be	AUX
njb-33	92	38	most	most	ADV
njb-33	92	39	predominant	predominant	ADJ
njb-33	92	40	organism	organism	NOUN
njb-33	92	41	followed	follow	VERB
njb-33	92	42	by	by	ADP
njb-33	92	43	klebsiella	klebsiella	PROPN
njb-33	92	44	pneumoniae	pneumoniae	NOUN
njb-33	92	45	(	(	PUNCT
njb-33	92	46	9.75	9.75	NUM
njb-33	92	47	%	%	NOUN
njb-33	92	48	)	)	PUNCT
njb-33	93	1	[	[	X
njb-33	93	2	8	8	NUM
njb-33	93	3	]	]	PUNCT
njb-33	93	4	.	.	PUNCT
njb-33	94	1	the	the	DET
njb-33	94	2	high	high	ADJ
njb-33	94	3	prevalence	prevalence	NOUN
njb-33	94	4	of	of	ADP
njb-33	94	5	e.	e.	PROPN
njb-33	94	6	coli	coli	PROPN
njb-33	94	7	in	in	ADP
njb-33	94	8	causing	cause	VERB
njb-33	94	9	uti	uti	PROPN
njb-33	94	10	also	also	ADV
njb-33	94	11	resembled	resemble	VERB
njb-33	94	12	with	with	ADP
njb-33	94	13	the	the	DET
njb-33	94	14	studies	study	NOUN
njb-33	94	15	by	by	ADP
njb-33	94	16	raza	raza	PROPN
njb-33	94	17	et	et	PROPN
njb-33	94	18	al	al	PROPN
njb-33	94	19	in	in	ADP
njb-33	94	20	kathmandu	kathmandu	NOUN
njb-33	94	21	,	,	PUNCT
njb-33	94	22	nepal	nepal	ADJ
njb-33	94	23	[	[	X
njb-33	94	24	9	9	NUM
njb-33	94	25	]	]	PUNCT
njb-33	94	26	and	and	CCONJ
njb-33	94	27	patel	patel	NOUN
njb-33	94	28	et	et	PROPN
njb-33	94	29	al	al	PROPN
njb-33	94	30	in	in	ADP
njb-33	94	31	india	india	PROPN
njb-33	95	1	[	[	PUNCT
njb-33	95	2	10	10	NUM
njb-33	95	3	]	]	PUNCT
njb-33	95	4	.	.	PUNCT
njb-33	96	1	e.	e.	PROPN
njb-33	96	2	coli	coli	PROPN
njb-33	96	3	can	can	AUX
njb-33	96	4	bind	bind	VERB
njb-33	96	5	to	to	ADP
njb-33	96	6	the	the	DET
njb-33	96	7	glycoconjugate	glycoconjugate	ADJ
njb-33	96	8	receptor	receptor	NOUN
njb-33	96	9	(	(	PUNCT
njb-33	96	10	gal	gal	VERB
njb-33	96	11	α	α	PROPN
njb-33	96	12	1	1	NUM
njb-33	96	13	-	-	SYM
njb-33	96	14	4	4	NUM
njb-33	96	15	gal	gal	NOUN
njb-33	96	16	)	)	PUNCT
njb-33	96	17	of	of	ADP
njb-33	96	18	the	the	DET
njb-33	96	19	uroepithelial	uroepithelial	ADJ
njb-33	96	20	cells	cell	NOUN
njb-33	96	21	of	of	ADP
njb-33	96	22	human	human	ADJ
njb-33	96	23	urinary	urinary	ADJ
njb-33	96	24	tract	tract	NOUN
njb-33	96	25	with	with	ADP
njb-33	96	26	its	its	PRON
njb-33	96	27	unique	unique	ADJ
njb-33	96	28	virulence	virulence	NOUN
njb-33	96	29	determinant	determinant	NOUN
njb-33	96	30	,	,	PUNCT
njb-33	96	31	the	the	DET
njb-33	96	32	p	p	NOUN
njb-33	96	33	pilus	pilus	NOUN
njb-33	96	34	(	(	PUNCT
njb-33	96	35	gal	gal	ADJ
njb-33	96	36	-	-	ADJ
njb-33	96	37	gal	gal	ADJ
njb-33	96	38	receptor	receptor	NOUN
njb-33	96	39	)	)	PUNCT
njb-33	96	40	so	so	SCONJ
njb-33	96	41	as	as	SCONJ
njb-33	96	42	to	to	PART
njb-33	96	43	initiate	initiate	VERB
njb-33	96	44	the	the	DET
njb-33	96	45	infection	infection	NOUN
njb-33	96	46	[	[	PUNCT
njb-33	96	47	11	11	NUM
njb-33	96	48	]	]	PUNCT
njb-33	96	49	.	.	PUNCT
njb-33	97	1	as	as	ADP
njb-33	97	2	in	in	ADP
njb-33	97	3	the	the	DET
njb-33	97	4	study	study	NOUN
njb-33	97	5	by	by	ADP
njb-33	97	6	gautam	gautam	PROPN
njb-33	97	7	et	et	NOUN
njb-33	97	8	al	al	PROPN
njb-33	97	9	[	[	PUNCT
njb-33	97	10	12	12	NUM
njb-33	97	11	]	]	PUNCT
njb-33	97	12	all	all	DET
njb-33	97	13	the	the	DET
njb-33	97	14	gram	gram	ADJ
njb-33	97	15	positive	positive	ADJ
njb-33	97	16	isolates	isolate	NOUN
njb-33	97	17	were	be	AUX
njb-33	97	18	staphylococcus	staphylococcus	NOUN
njb-33	97	19	aureus	aureus	NOUN
njb-33	97	20	and	and	CCONJ
njb-33	97	21	were	be	AUX
njb-33	97	22	obtained	obtain	VERB
njb-33	97	23	from	from	ADP
njb-33	97	24	female	female	ADJ
njb-33	97	25	patients	patient	NOUN
njb-33	97	26	only	only	ADV
njb-33	97	27	.	.	PUNCT
njb-33	98	1	antibiotic	antibiotic	ADJ
njb-33	98	2	resistance	resistance	NOUN
njb-33	98	3	is	be	AUX
njb-33	98	4	a	a	DET
njb-33	98	5	serious	serious	ADJ
njb-33	98	6	public	public	ADJ
njb-33	98	7	health	health	NOUN
njb-33	98	8	concern	concern	NOUN
njb-33	98	9	and	and	CCONJ
njb-33	98	10	is	be	AUX
njb-33	98	11	associated	associate	VERB
njb-33	98	12	with	with	ADP
njb-33	98	13	prolonged	prolonged	ADJ
njb-33	98	14	hospitalization	hospitalization	NOUN
njb-33	98	15	,	,	PUNCT
njb-33	98	16	high	high	ADJ
njb-33	98	17	health	health	NOUN
njb-33	98	18	-	-	PUNCT
njb-33	98	19	care	care	NOUN
njb-33	98	20	cost	cost	NOUN
njb-33	98	21	,	,	PUNCT
njb-33	98	22	increased	increase	VERB
njb-33	98	23	morbidity	morbidity	NOUN
njb-33	98	24	and	and	CCONJ
njb-33	98	25	mortality	mortality	NOUN
njb-33	98	26	.	.	PUNCT
njb-33	99	1	in	in	ADP
njb-33	99	2	our	our	PRON
njb-33	99	3	study	study	NOUN
njb-33	99	4	,	,	PUNCT
njb-33	99	5	gentamicin	gentamicin	PROPN
njb-33	99	6	(	(	PUNCT
njb-33	99	7	57.45	57.45	NUM
njb-33	99	8	%	%	NOUN
njb-33	99	9	)	)	PUNCT
njb-33	99	10	was	be	AUX
njb-33	99	11	found	find	VERB
njb-33	99	12	to	to	PART
njb-33	99	13	be	be	AUX
njb-33	99	14	the	the	DET
njb-33	99	15	most	most	ADV
njb-33	99	16	effective	effective	ADJ
njb-33	99	17	antibiotic	antibiotic	NOUN
njb-33	99	18	against	against	ADP
njb-33	99	19	gram	gram	NOUN
njb-33	99	20	negative	negative	ADJ
njb-33	99	21	bacteria	bacteria	NOUN
njb-33	99	22	followed	follow	VERB
njb-33	99	23	by	by	ADP
njb-33	99	24	ceftriaxone	ceftriaxone	PROPN
njb-33	99	25	(	(	PUNCT
njb-33	99	26	51.06	51.06	NUM
njb-33	99	27	%	%	NOUN
njb-33	99	28	)	)	PUNCT
njb-33	99	29	and	and	CCONJ
njb-33	99	30	nitrofurantoin	nitrofurantoin	NOUN
njb-33	99	31	(	(	PUNCT
njb-33	99	32	45.75	45.75	NUM
njb-33	99	33	%	%	NOUN
njb-33	99	34	)	)	PUNCT
njb-33	99	35	.	.	PUNCT
njb-33	100	1	in	in	ADP
njb-33	100	2	a	a	DET
njb-33	100	3	similar	similar	ADJ
njb-33	100	4	study	study	NOUN
njb-33	100	5	carried	carry	VERB
njb-33	100	6	out	out	ADP
njb-33	100	7	by	by	ADP
njb-33	100	8	jha	jha	NOUN
njb-33	100	9	and	and	CCONJ
njb-33	100	10	bapat	bapat	PROPN
njb-33	100	11	at	at	ADP
njb-33	100	12	sukhraraj	sukhraraj	PROPN
njb-33	100	13	tropical	tropical	PROPN
njb-33	100	14	hospital	hospital	PROPN
njb-33	100	15	,	,	PUNCT
njb-33	100	16	kathmandu	kathmandu	NOUN
njb-33	100	17	,	,	PUNCT
njb-33	100	18	nepal	nepal	ADJ
njb-33	100	19	92.5	92.5	NUM
njb-33	100	20	%	%	NOUN
njb-33	100	21	of	of	ADP
njb-33	100	22	urinary	urinary	ADJ
njb-33	100	23	isolates	isolate	NOUN
njb-33	100	24	were	be	AUX
njb-33	100	25	found	find	VERB
njb-33	100	26	to	to	PART
njb-33	100	27	be	be	AUX
njb-33	100	28	susceptible	susceptible	ADJ
njb-33	100	29	to	to	ADP
njb-33	100	30	gentamicin	gentamicin	NOUN
njb-33	100	31	[	[	PUNCT
njb-33	100	32	13	13	NUM
njb-33	100	33	]	]	PUNCT
njb-33	100	34	.	.	PUNCT
njb-33	101	1	in	in	ADP
njb-33	101	2	a	a	DET
njb-33	101	3	study	study	NOUN
njb-33	101	4	by	by	ADP
njb-33	101	5	khanal	khanal	ADJ
njb-33	101	6	50	50	NUM
njb-33	101	7	%	%	NOUN
njb-33	101	8	of	of	ADP
njb-33	101	9	gram	gram	ADJ
njb-33	101	10	negative	negative	ADJ
njb-33	101	11	organisms	organism	NOUN
njb-33	101	12	were	be	AUX
njb-33	101	13	sensitive	sensitive	ADJ
njb-33	101	14	to	to	ADP
njb-33	101	15	ceftriaxone	ceftriaxone	NOUN
njb-33	101	16	and	and	CCONJ
njb-33	101	17	58.34	58.34	NUM
njb-33	101	18	%	%	NOUN
njb-33	101	19	of	of	ADP
njb-33	101	20	the	the	DET
njb-33	101	21	gram	gram	PROPN
njb-33	101	22	nepal	nepal	ADJ
njb-33	101	23	journal	journal	NOUN
njb-33	101	24	of	of	ADP
njb-33	101	25	biotechnology	biotechnology	NOUN
njb-33	101	26	.	.	PUNCT
njb-33	102	1	d	d	X
njb-33	102	2	e	e	PROPN
njb-33	102	3	c	c	PROPN
njb-33	102	4	.	.	PUNCT
njb-33	103	1	2	2	NUM
njb-33	103	2	0	0	NUM
njb-33	103	3	1	1	NUM
njb-33	103	4	5	5	NUM
njb-33	103	5	vol	vol	NOUN
njb-33	103	6	.	.	PUNCT
njb-33	104	1	3	3	NUM
njb-33	104	2	,	,	PUNCT
njb-33	104	3	no	no	INTJ
njb-33	104	4	.	.	NOUN
njb-33	105	1	1:55	1:55	NUM
njb-33	105	2	-	-	SYM
njb-33	105	3	59	59	NUM
njb-33	105	4	awasthi	awasthi	NOUN
njb-33	105	5	et	et	PROPN
njb-33	105	6	al	al	PROPN
njb-33	105	7	.	.	PUNCT
njb-33	106	1	©	©	PROPN
njb-33	106	2	njb	njb	PROPN
njb-33	106	3	,	,	PUNCT
njb-33	106	4	biotechnology	biotechnology	NOUN
njb-33	106	5	society	society	NOUN
njb-33	106	6	of	of	ADP
njb-33	106	7	nepal	nepal	ADJ
njb-33	106	8	58	58	NUM
njb-33	106	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-33	106	10	negative	negative	ADJ
njb-33	106	11	isolates	isolate	NOUN
njb-33	106	12	were	be	AUX
njb-33	106	13	sensitive	sensitive	ADJ
njb-33	106	14	towards	towards	ADP
njb-33	106	15	nitrofurantoin	nitrofurantoin	NOUN
njb-33	106	16	[	[	NOUN
njb-33	106	17	8	8	NUM
njb-33	106	18	]	]	PUNCT
njb-33	106	19	.	.	PUNCT
njb-33	107	1	on	on	ADP
njb-33	107	2	the	the	DET
njb-33	107	3	other	other	ADJ
njb-33	107	4	hand	hand	NOUN
njb-33	107	5	,	,	PUNCT
njb-33	107	6	in	in	ADP
njb-33	107	7	our	our	PRON
njb-33	107	8	study	study	NOUN
njb-33	107	9	ampicillin	ampicillin	NOUN
njb-33	107	10	was	be	AUX
njb-33	107	11	found	find	VERB
njb-33	107	12	to	to	PART
njb-33	107	13	be	be	AUX
njb-33	107	14	the	the	DET
njb-33	107	15	least	least	ADJ
njb-33	107	16	effective	effective	ADJ
njb-33	107	17	drug	drug	NOUN
njb-33	107	18	against	against	ADP
njb-33	107	19	gram	gram	NOUN
njb-33	107	20	negative	negative	ADJ
njb-33	107	21	bacteria	bacteria	NOUN
njb-33	107	22	(	(	PUNCT
njb-33	107	23	5.32	5.32	NUM
njb-33	107	24	%	%	NOUN
njb-33	107	25	sensitive	sensitive	ADJ
njb-33	107	26	)	)	PUNCT
njb-33	107	27	.	.	PUNCT
njb-33	108	1	resistance	resistance	NOUN
njb-33	108	2	to	to	ADP
njb-33	108	3	penicillins	penicillin	NOUN
njb-33	108	4	may	may	AUX
njb-33	108	5	be	be	AUX
njb-33	108	6	determined	determine	VERB
njb-33	108	7	by	by	ADP
njb-33	108	8	the	the	DET
njb-33	108	9	organisms	organism	NOUN
njb-33	108	10	due	due	ADP
njb-33	108	11	to	to	ADP
njb-33	108	12	the	the	DET
njb-33	108	13	production	production	NOUN
njb-33	108	14	of	of	ADP
njb-33	108	15	penicillin	penicillin	NOUN
njb-33	108	16	destroying	destroy	VERB
njb-33	108	17	enzymes	enzyme	NOUN
njb-33	108	18	(	(	PUNCT
njb-33	108	19	βlactamase	βlactamase	NOUN
njb-33	108	20	)	)	PUNCT
njb-33	108	21	.	.	PUNCT
njb-33	109	1	15.96	15.96	NUM
njb-33	109	2	%	%	NOUN
njb-33	109	3	,	,	PUNCT
njb-33	109	4	29.79	29.79	NUM
njb-33	109	5	%	%	NOUN
njb-33	109	6	and	and	CCONJ
njb-33	109	7	32.98	32.98	NUM
njb-33	109	8	%	%	NOUN
njb-33	109	9	of	of	ADP
njb-33	109	10	the	the	DET
njb-33	109	11	gram	gram	ADJ
njb-33	109	12	negative	negative	ADJ
njb-33	109	13	bacilli	bacilli	PROPN
njb-33	109	14	were	be	AUX
njb-33	109	15	susceptible	susceptible	ADJ
njb-33	109	16	to	to	ADP
njb-33	109	17	nalidixic	nalidixic	ADJ
njb-33	109	18	acid	acid	NOUN
njb-33	109	19	,	,	PUNCT
njb-33	109	20	ofloxacin	ofloxacin	NOUN
njb-33	109	21	and	and	CCONJ
njb-33	109	22	cotrimoxazole	cotrimoxazole	PROPN
njb-33	109	23	respectively	respectively	ADV
njb-33	109	24	.	.	PUNCT
njb-33	110	1	these	these	DET
njb-33	110	2	results	result	NOUN
njb-33	110	3	are	be	AUX
njb-33	110	4	in	in	ADP
njb-33	110	5	accordance	accordance	NOUN
njb-33	110	6	with	with	ADP
njb-33	110	7	the	the	DET
njb-33	110	8	results	result	NOUN
njb-33	110	9	of	of	ADP
njb-33	110	10	shrestha	shrestha	PROPN
njb-33	111	1	[	[	X
njb-33	111	2	5	5	NUM
njb-33	111	3	]	]	X
njb-33	111	4	.	.	PUNCT
njb-33	112	1	similar	similar	ADJ
njb-33	112	2	findings	finding	NOUN
njb-33	112	3	were	be	AUX
njb-33	112	4	also	also	ADV
njb-33	112	5	given	give	VERB
njb-33	112	6	by	by	ADP
njb-33	112	7	gautam	gautam	PROPN
njb-33	112	8	et	et	NOUN
njb-33	112	9	al	al	PROPN
njb-33	113	1	[	[	PUNCT
njb-33	113	2	12	12	NUM
njb-33	113	3	]	]	PUNCT
njb-33	113	4	and	and	CCONJ
njb-33	113	5	sharma	sharma	PROPN
njb-33	113	6	et	et	PROPN
njb-33	113	7	al	al	PROPN
njb-33	114	1	[	[	PUNCT
njb-33	114	2	4	4	NUM
njb-33	114	3	]	]	PUNCT
njb-33	114	4	.	.	PUNCT
njb-33	115	1	among	among	ADP
njb-33	115	2	gram	gram	NOUN
njb-33	115	3	positive	positive	ADJ
njb-33	115	4	cocci	cocci	PROPN
njb-33	115	5	gentamicin	gentamicin	PROPN
njb-33	115	6	was	be	AUX
njb-33	115	7	found	find	VERB
njb-33	115	8	to	to	PART
njb-33	115	9	be	be	AUX
njb-33	115	10	100	100	NUM
njb-33	115	11	%	%	NOUN
njb-33	115	12	effective	effective	ADJ
njb-33	115	13	where	where	SCONJ
njb-33	115	14	as	as	ADV
njb-33	115	15	nalidixic	nalidixic	ADJ
njb-33	115	16	acid	acid	NOUN
njb-33	115	17	and	and	CCONJ
njb-33	115	18	nitrofurantion	nitrofurantion	NOUN
njb-33	115	19	were	be	AUX
njb-33	115	20	found	find	VERB
njb-33	115	21	least	least	ADV
njb-33	115	22	effective	effective	ADJ
njb-33	115	23	with	with	ADP
njb-33	115	24	25	25	NUM
njb-33	115	25	%	%	NOUN
njb-33	115	26	of	of	ADP
njb-33	115	27	the	the	DET
njb-33	115	28	isolates	isolate	NOUN
njb-33	115	29	being	be	AUX
njb-33	115	30	sensitive	sensitive	ADJ
njb-33	115	31	to	to	ADP
njb-33	115	32	each	each	DET
njb-33	115	33	antibiotic	antibiotic	ADJ
njb-33	115	34	.	.	PUNCT
njb-33	116	1	the	the	DET
njb-33	116	2	exposure	exposure	NOUN
njb-33	116	3	of	of	ADP
njb-33	116	4	the	the	DET
njb-33	116	5	bacteria	bacteria	NOUN
njb-33	116	6	to	to	ADP
njb-33	116	7	antibiotic	antibiotic	ADJ
njb-33	116	8	causes	cause	VERB
njb-33	116	9	selective	selective	ADJ
njb-33	116	10	pressure	pressure	NOUN
njb-33	116	11	causing	cause	VERB
njb-33	116	12	the	the	DET
njb-33	116	13	killing	killing	NOUN
njb-33	116	14	of	of	ADP
njb-33	116	15	susceptible	susceptible	ADJ
njb-33	116	16	bacteria	bacteria	NOUN
njb-33	116	17	allowing	allow	VERB
njb-33	116	18	the	the	DET
njb-33	116	19	resistant	resistant	ADJ
njb-33	116	20	ones	one	NOUN
njb-33	116	21	to	to	PART
njb-33	116	22	survive	survive	VERB
njb-33	116	23	.	.	PUNCT
njb-33	117	1	the	the	DET
njb-33	117	2	rapid	rapid	ADJ
njb-33	117	3	development	development	NOUN
njb-33	117	4	of	of	ADP
njb-33	117	5	the	the	DET
njb-33	117	6	antibiotic	antibiotic	ADJ
njb-33	117	7	resistance	resistance	NOUN
njb-33	117	8	among	among	ADP
njb-33	117	9	the	the	DET
njb-33	117	10	bacteria	bacteria	NOUN
njb-33	117	11	is	be	AUX
njb-33	117	12	attributed	attribute	VERB
njb-33	117	13	to	to	ADP
njb-33	117	14	the	the	DET
njb-33	117	15	haphazard	haphazard	ADJ
njb-33	117	16	use	use	NOUN
njb-33	117	17	of	of	ADP
njb-33	117	18	antibiotics	antibiotic	NOUN
njb-33	117	19	[	[	PUNCT
njb-33	117	20	14	14	NUM
njb-33	117	21	]	]	PUNCT
njb-33	117	22	.	.	PUNCT
njb-33	118	1	the	the	DET
njb-33	118	2	problem	problem	NOUN
njb-33	118	3	of	of	ADP
njb-33	118	4	the	the	DET
njb-33	118	5	drug	drug	NOUN
njb-33	118	6	resistance	resistance	NOUN
njb-33	118	7	among	among	ADP
njb-33	118	8	bacteria	bacteria	NOUN
njb-33	118	9	is	be	AUX
njb-33	118	10	more	more	ADV
njb-33	118	11	prevalent	prevalent	ADJ
njb-33	118	12	in	in	ADP
njb-33	118	13	developing	develop	VERB
njb-33	118	14	countries	country	NOUN
njb-33	118	15	due	due	ADJ
njb-33	118	16	to	to	ADP
njb-33	118	17	lack	lack	NOUN
njb-33	118	18	of	of	ADP
njb-33	118	19	awareness	awareness	NOUN
njb-33	118	20	and	and	CCONJ
njb-33	118	21	lack	lack	NOUN
njb-33	118	22	of	of	ADP
njb-33	118	23	effective	effective	ADJ
njb-33	118	24	implementation	implementation	NOUN
njb-33	118	25	of	of	ADP
njb-33	118	26	the	the	DET
njb-33	118	27	policy	policy	NOUN
njb-33	118	28	that	that	PRON
njb-33	118	29	regulates	regulate	VERB
njb-33	118	30	the	the	DET
njb-33	118	31	use	use	NOUN
njb-33	118	32	of	of	ADP
njb-33	118	33	antibiotics	antibiotic	NOUN
njb-33	118	34	.	.	PUNCT
njb-33	119	1	out	out	ADP
njb-33	119	2	of	of	ADP
njb-33	119	3	98	98	NUM
njb-33	119	4	isolates	isolate	NOUN
njb-33	119	5	,	,	PUNCT
njb-33	119	6	42.86	42.86	NUM
njb-33	119	7	%	%	NOUN
njb-33	119	8	were	be	AUX
njb-33	119	9	found	find	VERB
njb-33	119	10	to	to	PART
njb-33	119	11	be	be	AUX
njb-33	119	12	multi	multi	ADJ
njb-33	119	13	drug	drug	NOUN
njb-33	119	14	resistant	resistant	ADJ
njb-33	119	15	.	.	PUNCT
njb-33	120	1	the	the	DET
njb-33	120	2	finding	finding	NOUN
njb-33	120	3	of	of	ADP
njb-33	120	4	the	the	DET
njb-33	120	5	present	present	ADJ
njb-33	120	6	study	study	NOUN
njb-33	120	7	was	be	AUX
njb-33	120	8	supported	support	VERB
njb-33	120	9	by	by	ADP
njb-33	120	10	the	the	DET
njb-33	120	11	results	result	NOUN
njb-33	120	12	of	of	ADP
njb-33	120	13	the	the	DET
njb-33	120	14	study	study	NOUN
njb-33	120	15	done	do	VERB
njb-33	120	16	by	by	ADP
njb-33	120	17	khanal	khanal	ADJ
njb-33	120	18	[	[	X
njb-33	120	19	8	8	NUM
njb-33	120	20	]	]	PUNCT
njb-33	120	21	and	and	CCONJ
njb-33	120	22	upadhaya	upadhaya	PROPN
njb-33	120	23	et	et	PROPN
njb-33	120	24	al	al	PROPN
njb-33	121	1	[	[	PUNCT
njb-33	121	2	15	15	NUM
njb-33	121	3	]	]	PUNCT
njb-33	121	4	noted	note	VERB
njb-33	121	5	the	the	DET
njb-33	121	6	mdr	mdr	NOUN
njb-33	121	7	causing	cause	VERB
njb-33	121	8	uti	uti	PROPN
njb-33	121	9	to	to	PART
njb-33	121	10	be	be	AUX
njb-33	121	11	56.09	56.09	NUM
njb-33	121	12	%	%	NOUN
njb-33	121	13	and	and	CCONJ
njb-33	121	14	48	48	NUM
njb-33	121	15	%	%	NOUN
njb-33	121	16	respectively	respectively	ADV
njb-33	121	17	.	.	PUNCT
njb-33	122	1	in	in	ADP
njb-33	122	2	our	our	PRON
njb-33	122	3	study	study	NOUN
njb-33	122	4	48.08	48.08	NUM
njb-33	122	5	%	%	NOUN
njb-33	122	6	of	of	ADP
njb-33	122	7	the	the	DET
njb-33	122	8	e.	e.	PROPN
njb-33	122	9	coli	coli	PROPN
njb-33	122	10	,	,	PUNCT
njb-33	122	11	19.05	19.05	NUM
njb-33	122	12	%	%	NOUN
njb-33	122	13	of	of	ADP
njb-33	122	14	the	the	DET
njb-33	122	15	k.	k.	PROPN
njb-33	122	16	pneumonia	pneumonia	NOUN
njb-33	122	17	,	,	PUNCT
njb-33	122	18	50	50	NUM
njb-33	122	19	%	%	NOUN
njb-33	122	20	of	of	ADP
njb-33	122	21	the	the	DET
njb-33	122	22	p.	p.	PROPN
njb-33	122	23	aeruginosa	aeruginosa	PROPN
njb-33	122	24	,	,	PUNCT
njb-33	122	25	85.71	85.71	NUM
njb-33	122	26	%	%	NOUN
njb-33	122	27	of	of	ADP
njb-33	122	28	the	the	DET
njb-33	122	29	p.	p.	NOUN
njb-33	122	30	vulgaris	vulgaris	NOUN
njb-33	122	31	and	and	CCONJ
njb-33	122	32	25	25	NUM
njb-33	122	33	%	%	NOUN
njb-33	122	34	of	of	ADP
njb-33	122	35	the	the	DET
njb-33	122	36	staphylococcus	staphylococcus	NOUN
njb-33	122	37	aureus	aureus	PROPN
njb-33	122	38	were	be	AUX
njb-33	122	39	found	find	VERB
njb-33	122	40	to	to	PART
njb-33	122	41	be	be	AUX
njb-33	122	42	mdr	mdr	PROPN
njb-33	122	43	.	.	PUNCT
njb-33	123	1	similar	similar	ADJ
njb-33	123	2	findings	finding	NOUN
njb-33	123	3	were	be	AUX
njb-33	123	4	obtained	obtain	VERB
njb-33	123	5	in	in	ADP
njb-33	123	6	the	the	DET
njb-33	123	7	study	study	NOUN
njb-33	123	8	done	do	VERB
njb-33	123	9	by	by	ADP
njb-33	123	10	tuladhar	tuladhar	NOUN
njb-33	123	11	et	et	PROPN
njb-33	123	12	al	al	PROPN
njb-33	123	13	[	[	PUNCT
njb-33	123	14	16	16	NUM
njb-33	123	15	]	]	PUNCT
njb-33	123	16	in	in	ADP
njb-33	123	17	a	a	DET
njb-33	123	18	hospital	hospital	NOUN
njb-33	123	19	in	in	ADP
njb-33	123	20	kathmandu	kathmandu	NOUN
njb-33	123	21	,	,	PUNCT
njb-33	123	22	where	where	SCONJ
njb-33	123	23	mdr	mdr	NOUN
njb-33	123	24	bacterial	bacterial	ADJ
njb-33	123	25	strains	strain	NOUN
njb-33	123	26	were	be	AUX
njb-33	123	27	detected	detect	VERB
njb-33	123	28	in	in	ADP
njb-33	123	29	35.21	35.21	NUM
njb-33	123	30	%	%	NOUN
njb-33	123	31	with	with	ADP
njb-33	123	32	the	the	DET
njb-33	123	33	most	most	ADV
njb-33	123	34	predominant	predominant	ADJ
njb-33	123	35	mdr	mdr	PROPN
njb-33	123	36	bacterium	bacterium	NOUN
njb-33	123	37	being	be	AUX
njb-33	123	38	e.	e.	PROPN
njb-33	123	39	coli	coli	PROPN
njb-33	123	40	followed	follow	VERB
njb-33	123	41	by	by	ADP
njb-33	123	42	klebsiella	klebsiella	PROPN
njb-33	123	43	spp	spp	PROPN
njb-33	123	44	.	.	PUNCT
njb-33	124	1	increasing	increase	VERB
njb-33	124	2	haphazard	haphazard	ADJ
njb-33	124	3	use	use	NOUN
njb-33	124	4	of	of	ADP
njb-33	124	5	antibiotics	antibiotic	NOUN
njb-33	124	6	and	and	CCONJ
njb-33	124	7	sales	sale	NOUN
njb-33	124	8	of	of	ADP
njb-33	124	9	substandard	substandard	ADJ
njb-33	124	10	drugs	drug	NOUN
njb-33	124	11	are	be	AUX
njb-33	124	12	responsible	responsible	ADJ
njb-33	124	13	for	for	ADP
njb-33	124	14	development	development	NOUN
njb-33	124	15	of	of	ADP
njb-33	124	16	multi	multi	ADJ
njb-33	124	17	drug	drug	NOUN
njb-33	124	18	resistance	resistance	NOUN
njb-33	124	19	among	among	ADP
njb-33	124	20	the	the	DET
njb-33	124	21	bacteria	bacteria	NOUN
njb-33	124	22	[	[	PUNCT
njb-33	124	23	17	17	NUM
njb-33	124	24	]	]	PUNCT
njb-33	124	25	.	.	PUNCT
njb-33	125	1	due	due	ADP
njb-33	125	2	to	to	ADP
njb-33	125	3	development	development	NOUN
njb-33	125	4	of	of	ADP
njb-33	125	5	drug	drug	NOUN
njb-33	125	6	resistance	resistance	NOUN
njb-33	125	7	against	against	ADP
njb-33	125	8	commonly	commonly	ADV
njb-33	125	9	used	use	VERB
njb-33	125	10	antibiotics	antibiotic	NOUN
njb-33	125	11	among	among	ADP
njb-33	125	12	the	the	DET
njb-33	125	13	bacteria	bacteria	NOUN
njb-33	125	14	the	the	DET
njb-33	125	15	therapeutic	therapeutic	ADJ
njb-33	125	16	options	option	NOUN
njb-33	125	17	have	have	AUX
njb-33	125	18	become	become	VERB
njb-33	125	19	limited	limited	ADJ
njb-33	125	20	.	.	PUNCT
njb-33	126	1	the	the	DET
njb-33	126	2	isolation	isolation	NOUN
njb-33	126	3	of	of	ADP
njb-33	126	4	the	the	DET
njb-33	126	5	multi	multi	ADJ
njb-33	126	6	drug	drug	NOUN
njb-33	126	7	resistance	resistance	NOUN
njb-33	126	8	bacteria	bacteria	NOUN
njb-33	126	9	from	from	ADP
njb-33	126	10	the	the	DET
njb-33	126	11	patients	patient	NOUN
njb-33	126	12	with	with	ADP
njb-33	126	13	no	no	DET
njb-33	126	14	past	past	ADJ
njb-33	126	15	history	history	NOUN
njb-33	126	16	of	of	ADP
njb-33	126	17	hospitalization	hospitalization	NOUN
njb-33	126	18	indicates	indicate	VERB
njb-33	126	19	that	that	SCONJ
njb-33	126	20	the	the	DET
njb-33	126	21	infection	infection	NOUN
njb-33	126	22	was	be	AUX
njb-33	126	23	community	community	NOUN
njb-33	126	24	acquired	acquire	VERB
njb-33	126	25	.	.	PUNCT
njb-33	127	1	the	the	DET
njb-33	127	2	involvement	involvement	NOUN
njb-33	127	3	of	of	ADP
njb-33	127	4	such	such	ADJ
njb-33	127	5	large	large	ADJ
njb-33	127	6	number	number	NOUN
njb-33	127	7	of	of	ADP
njb-33	127	8	multidrug	multidrug	NOUN
njb-33	127	9	resistant	resistant	ADJ
njb-33	127	10	bacteria	bacteria	NOUN
njb-33	127	11	in	in	ADP
njb-33	127	12	causing	cause	VERB
njb-33	127	13	community	community	NOUN
njb-33	127	14	acquired	acquire	VERB
njb-33	127	15	urinary	urinary	ADJ
njb-33	127	16	tract	tract	NOUN
njb-33	127	17	infections	infection	NOUN
njb-33	127	18	is	be	AUX
njb-33	127	19	very	very	ADV
njb-33	127	20	serious	serious	ADJ
njb-33	127	21	issue	issue	NOUN
njb-33	127	22	and	and	CCONJ
njb-33	127	23	can	can	AUX
njb-33	127	24	not	not	PART
njb-33	127	25	be	be	AUX
njb-33	127	26	neglected	neglect	VERB
njb-33	127	27	.	.	PUNCT
njb-33	128	1	some	some	DET
njb-33	128	2	abrupt	abrupt	ADJ
njb-33	128	3	initiatives	initiative	NOUN
njb-33	128	4	should	should	AUX
njb-33	128	5	be	be	AUX
njb-33	128	6	taken	take	VERB
njb-33	128	7	by	by	ADP
njb-33	128	8	the	the	DET
njb-33	128	9	responsible	responsible	ADJ
njb-33	128	10	authorities	authority	NOUN
njb-33	128	11	to	to	PART
njb-33	128	12	improve	improve	VERB
njb-33	128	13	or	or	CCONJ
njb-33	128	14	at	at	ADP
njb-33	128	15	least	least	ADJ
njb-33	128	16	avoid	avoid	VERB
njb-33	128	17	the	the	DET
njb-33	128	18	further	further	ADJ
njb-33	128	19	worsening	worsening	NOUN
njb-33	128	20	of	of	ADP
njb-33	128	21	the	the	DET
njb-33	128	22	situation	situation	NOUN
njb-33	128	23	.	.	PUNCT
njb-33	129	1	conclusion	conclusion	NOUN
njb-33	129	2	involvement	involvement	NOUN
njb-33	129	3	of	of	ADP
njb-33	129	4	multidrug	multidrug	NOUN
njb-33	129	5	resistant	resistant	ADJ
njb-33	129	6	bacteria	bacteria	NOUN
njb-33	129	7	in	in	ADP
njb-33	129	8	causing	cause	VERB
njb-33	129	9	large	large	ADJ
njb-33	129	10	numbers	number	NOUN
njb-33	129	11	of	of	ADP
njb-33	129	12	community	community	NOUN
njb-33	129	13	acquired	acquire	VERB
njb-33	129	14	infections	infection	NOUN
njb-33	129	15	is	be	AUX
njb-33	129	16	a	a	DET
njb-33	129	17	very	very	ADV
njb-33	129	18	serious	serious	ADJ
njb-33	129	19	public	public	ADJ
njb-33	129	20	health	health	NOUN
njb-33	129	21	concern	concern	NOUN
njb-33	129	22	.	.	PUNCT
njb-33	130	1	some	some	DET
njb-33	130	2	necessary	necessary	ADJ
njb-33	130	3	initiatives	initiative	NOUN
njb-33	130	4	should	should	AUX
njb-33	130	5	be	be	AUX
njb-33	130	6	taken	take	VERB
njb-33	130	7	immediately	immediately	ADV
njb-33	130	8	to	to	PART
njb-33	130	9	control	control	VERB
njb-33	130	10	the	the	DET
njb-33	130	11	situation	situation	NOUN
njb-33	130	12	.	.	PUNCT
njb-33	131	1	competing	compete	VERB
njb-33	131	2	interests	interest	NOUN
njb-33	131	3	the	the	DET
njb-33	131	4	authors	author	NOUN
njb-33	131	5	declare	declare	VERB
njb-33	131	6	that	that	SCONJ
njb-33	131	7	they	they	PRON
njb-33	131	8	have	have	VERB
njb-33	131	9	no	no	DET
njb-33	131	10	competing	compete	VERB
njb-33	131	11	interests	interest	NOUN
njb-33	131	12	.	.	PUNCT
njb-33	132	1	references	reference	NOUN
njb-33	132	2	1	1	NUM
njb-33	132	3	.	.	PUNCT
njb-33	132	4	leigh	leigh	PROPN
njb-33	132	5	da	da	PROPN
njb-33	132	6	,	,	PUNCT
njb-33	132	7	smith	smith	PROPN
njb-33	132	8	gr	gr	PROPN
njb-33	132	9	,	,	PUNCT
njb-33	132	10	easman	easman	PROPN
njb-33	132	11	csf	csf	NOUN
njb-33	132	12	:	:	PUNCT
njb-33	132	13	topley	topley	PROPN
njb-33	132	14	and	and	CCONJ
njb-33	132	15	wilson	wilson	PROPN
njb-33	132	16	's	's	PART
njb-33	132	17	principles	principle	NOUN
njb-33	132	18	of	of	ADP
njb-33	132	19	bacteriology	bacteriology	NOUN
njb-33	132	20	,	,	PUNCT
njb-33	132	21	urology	urology	NOUN
njb-33	132	22	and	and	CCONJ
njb-33	132	23	immunology	immunology	NOUN
njb-33	132	24	,	,	PUNCT
njb-33	132	25	bacterial	bacterial	ADJ
njb-33	132	26	diseases	disease	NOUN
njb-33	132	27	,	,	PUNCT
njb-33	132	28	8th	8th	ADJ
njb-33	132	29	edition	edition	NOUN
njb-33	132	30	,	,	PUNCT
njb-33	132	31	frome	frome	PROPN
njb-33	132	32	and	and	CCONJ
njb-33	132	33	london	london	PROPN
njb-33	132	34	;	;	PUNCT
njb-33	132	35	butter	butter	NOUN
njb-33	132	36	and	and	CCONJ
njb-33	132	37	tanner	tanner	NOUN
njb-33	132	38	ltd	ltd	PROPN
njb-33	132	39	1990,3:197	1990,3:197	NUM
njb-33	132	40	-	-	SYM
njb-33	132	41	214	214	NUM
njb-33	132	42	.	.	NUM
njb-33	132	43	2	2	X
njb-33	132	44	.	.	PUNCT
njb-33	132	45	forbes	forbes	PROPN
njb-33	132	46	ba	ba	PROPN
njb-33	132	47	,	,	PUNCT
njb-33	132	48	sahm	sahm	NOUN
njb-33	132	49	df	df	NOUN
njb-33	132	50	,	,	PUNCT
njb-33	132	51	weissfeld	weissfeld	VERB
njb-33	132	52	as	as	ADP
njb-33	132	53	:	:	PUNCT
njb-33	132	54	baily	baily	PROPN
njb-33	132	55	and	and	CCONJ
njb-33	132	56	scott	scott	PROPN
njb-33	132	57	's	's	PART
njb-33	132	58	diagnostic	diagnostic	ADJ
njb-33	132	59	microbiology	microbiology	NOUN
njb-33	132	60	,	,	PUNCT
njb-33	132	61	11th	11th	PROPN
njb-33	132	62	edition	edition	NOUN
njb-33	132	63	.	.	PUNCT
njb-33	132	64	mosby	mosby	PROPN
njb-33	132	65	inc	inc	PROPN
njb-33	132	66	,	,	PUNCT
njb-33	132	67	usa	usa	PROPN
njb-33	132	68	;	;	PUNCT
njb-33	132	69	2002	2002	NUM
njb-33	132	70	.	.	PUNCT
njb-33	133	1	3	3	X
njb-33	133	2	.	.	X
njb-33	133	3	tuladhar	tuladhar	PROPN
njb-33	133	4	nr	nr	ADP
njb-33	133	5	:	:	PUNCT
njb-33	133	6	a	a	DET
njb-33	133	7	report	report	NOUN
njb-33	133	8	:	:	PUNCT
njb-33	133	9	surveillance	surveillance	NOUN
njb-33	133	10	of	of	ADP
njb-33	133	11	multiple	multiple	ADJ
njb-33	133	12	drug	drug	NOUN
njb-33	133	13	resistant	resistant	ADJ
njb-33	133	14	(	(	PUNCT
njb-33	133	15	mdr	mdr	PROPN
njb-33	133	16	)	)	PUNCT
njb-33	133	17	bacterial	bacterial	ADJ
njb-33	133	18	infection	infection	NOUN
njb-33	133	19	among	among	ADP
njb-33	133	20	the	the	DET
njb-33	133	21	patients	patient	NOUN
njb-33	133	22	attending	attend	VERB
njb-33	133	23	to	to	ADP
njb-33	133	24	different	different	ADJ
njb-33	133	25	out	out	ADP
njb-33	133	26	patient	patient	ADJ
njb-33	133	27	departments	department	NOUN
njb-33	133	28	(	(	PUNCT
njb-33	133	29	opd	opd	PROPN
njb-33	133	30	)	)	PUNCT
njb-33	133	31	and	and	CCONJ
njb-33	133	32	hospitalized	hospitalize	VERB
njb-33	133	33	patients	patient	NOUN
njb-33	133	34	in	in	ADP
njb-33	133	35	tribhuvan	tribhuvan	PROPN
njb-33	133	36	university	university	PROPN
njb-33	133	37	teaching	teaching	NOUN
njb-33	133	38	hospital	hospital	NOUN
njb-33	133	39	;	;	PUNCT
njb-33	133	40	2001	2001	NUM
njb-33	133	41	.	.	PUNCT
njb-33	134	1	4	4	NUM
njb-33	134	2	.	.	PROPN
njb-33	134	3	sharma	sharma	PROPN
njb-33	134	4	ar	ar	PROPN
njb-33	134	5	,	,	PUNCT
njb-33	134	6	bhatta	bhatta	PROPN
njb-33	134	7	dr	dr	PROPN
njb-33	134	8	,	,	PUNCT
njb-33	134	9	shrestha	shrestha	PROPN
njb-33	134	10	j	j	PROPN
njb-33	134	11	,	,	PUNCT
njb-33	134	12	banjara	banjara	PROPN
njb-33	134	13	mr	mr	PROPN
njb-33	134	14	:	:	PUNCT
njb-33	134	15	antimicrobial	antimicrobial	ADJ
njb-33	134	16	susceptibility	susceptibility	NOUN
njb-33	134	17	pattern	pattern	NOUN
njb-33	134	18	of	of	ADP
njb-33	134	19	escherichia	escherichia	NOUN
njb-33	134	20	coli	coli	NOUN
njb-33	134	21	isolated	isolate	VERB
njb-33	134	22	from	from	ADP
njb-33	134	23	urinary	urinary	ADJ
njb-33	134	24	tract	tract	NOUN
njb-33	134	25	infected	infect	VERB
njb-33	134	26	patients	patient	NOUN
njb-33	134	27	attending	attend	VERB
njb-33	134	28	bir	bir	PROPN
njb-33	134	29	hospital	hospital	PROPN
njb-33	134	30	.	.	PUNCT
njb-33	135	1	nepal	nepal	PROPN
njb-33	135	2	j	j	PROPN
njb-33	135	3	science	science	PROPN
njb-33	135	4	and	and	CCONJ
njb-33	135	5	technology	technology	NOUN
njb-33	135	6	2013	2013	NUM
njb-33	135	7	,	,	PUNCT
njb-33	135	8	14(1	14(1	NUM
njb-33	135	9	):	):	PUNCT
njb-33	135	10	177	177	NUM
njb-33	135	11	-	-	SYM
njb-33	135	12	184	184	NUM
njb-33	135	13	.	.	SYM
njb-33	135	14	5	5	X
njb-33	135	15	.	.	PUNCT
njb-33	136	1	shrestha	shrestha	PROPN
njb-33	136	2	p	p	X
njb-33	136	3	:	:	PUNCT
njb-33	136	4	study	study	NOUN
njb-33	136	5	of	of	ADP
njb-33	136	6	bacteria	bacteria	NOUN
njb-33	136	7	causing	cause	VERB
njb-33	136	8	urinary	urinary	ADJ
njb-33	136	9	tract	tract	NOUN
njb-33	136	10	infection	infection	NOUN
njb-33	136	11	and	and	CCONJ
njb-33	136	12	their	their	PRON
njb-33	136	13	antimicrobial	antimicrobial	ADJ
njb-33	136	14	resistance	resistance	NOUN
njb-33	136	15	trend	trend	NOUN
njb-33	136	16	at	at	ADP
njb-33	136	17	national	national	ADJ
njb-33	136	18	public	public	PROPN
njb-33	136	19	health	health	PROPN
njb-33	136	20	laboratory	laboratory	NOUN
njb-33	136	21	.	.	PUNCT
njb-33	137	1	msc	msc	PROPN
njb-33	137	2	thesis	thesis	PROPN
njb-33	137	3	.	.	PUNCT
njb-33	138	1	tribhuvan	tribhuvan	PROPN
njb-33	138	2	university	university	PROPN
njb-33	138	3	,	,	PUNCT
njb-33	138	4	central	central	ADJ
njb-33	138	5	department	department	NOUN
njb-33	138	6	of	of	ADP
njb-33	138	7	microbiology	microbiology	NOUN
njb-33	138	8	;	;	PUNCT
njb-33	138	9	2007	2007	NUM
njb-33	138	10	.	.	PUNCT
njb-33	139	1	6	6	NUM
njb-33	139	2	.	.	X
njb-33	139	3	baral	baral	ADJ
njb-33	139	4	p	p	PROPN
njb-33	139	5	,	,	PUNCT
njb-33	139	6	neupane	neupane	PROPN
njb-33	139	7	s	s	PROPN
njb-33	139	8	,	,	PUNCT
njb-33	139	9	marasini	marasini	PROPN
njb-33	139	10	bp	bp	PROPN
njb-33	139	11	,	,	PUNCT
njb-33	139	12	ghimire	ghimire	PROPN
njb-33	139	13	kr	kr	PROPN
njb-33	139	14	,	,	PUNCT
njb-33	139	15	lekhak	lekhak	PROPN
njb-33	139	16	b	b	PROPN
njb-33	139	17	,	,	PUNCT
njb-33	139	18	shrestha	shrestha	PROPN
njb-33	139	19	b	b	PROPN
njb-33	139	20	:	:	PUNCT
njb-33	139	21	high	high	ADJ
njb-33	139	22	prevalence	prevalence	NOUN
njb-33	139	23	of	of	ADP
njb-33	139	24	multidrug	multidrug	NOUN
njb-33	139	25	resistance	resistance	NOUN
njb-33	139	26	in	in	ADP
njb-33	139	27	bacterial	bacterial	ADJ
njb-33	139	28	uropathogens	uropathogen	NOUN
njb-33	139	29	from	from	ADP
njb-33	139	30	kathmandu	kathmandu	NOUN
njb-33	139	31	,	,	PUNCT
njb-33	139	32	nepal	nepal	ADJ
njb-33	139	33	.	.	PUNCT
njb-33	140	1	bmc	bmc	PROPN
njb-33	140	2	research	research	PROPN
njb-33	140	3	notes	note	NOUN
njb-33	140	4	2012,5:38	2012,5:38	PROPN
njb-33	140	5	.	.	PUNCT
njb-33	140	6	nepal	nepal	ADJ
njb-33	140	7	journal	journal	PROPN
njb-33	140	8	of	of	ADP
njb-33	140	9	biotechnology	biotechnology	NOUN
njb-33	140	10	.	.	PUNCT
njb-33	141	1	d	d	X
njb-33	141	2	e	e	PROPN
njb-33	141	3	c	c	PROPN
njb-33	141	4	.	.	PUNCT
njb-33	142	1	2	2	NUM
njb-33	142	2	0	0	NUM
njb-33	142	3	1	1	NUM
njb-33	142	4	5	5	NUM
njb-33	142	5	vol	vol	NOUN
njb-33	142	6	.	.	PUNCT
njb-33	143	1	3	3	NUM
njb-33	143	2	,	,	PUNCT
njb-33	143	3	no	no	INTJ
njb-33	143	4	.	.	NOUN
njb-33	144	1	1:55	1:55	NUM
njb-33	144	2	-	-	SYM
njb-33	144	3	59	59	NUM
njb-33	144	4	awasthi	awasthi	NOUN
njb-33	144	5	et	et	PROPN
njb-33	144	6	al	al	PROPN
njb-33	144	7	.	.	PUNCT
njb-33	145	1	©	©	PROPN
njb-33	145	2	njb	njb	PROPN
njb-33	145	3	,	,	PUNCT
njb-33	145	4	biotechnology	biotechnology	NOUN
njb-33	145	5	society	society	NOUN
njb-33	145	6	of	of	ADP
njb-33	145	7	nepal	nepal	ADJ
njb-33	145	8	59	59	NUM
njb-33	145	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-33	145	10	7	7	NUM
njb-33	145	11	.	.	PUNCT
njb-33	146	1	karki	karki	PROPN
njb-33	146	2	a	a	PRON
njb-33	146	3	,	,	PUNCT
njb-33	146	4	tiwari	tiwari	PROPN
njb-33	146	5	br	br	PROPN
njb-33	146	6	,	,	PUNCT
njb-33	146	7	pradhan	pradhan	PROPN
njb-33	146	8	sb	sb	PROPN
njb-33	146	9	:	:	PUNCT
njb-33	146	10	study	study	NOUN
njb-33	146	11	of	of	ADP
njb-33	146	12	bacteria	bacteria	NOUN
njb-33	146	13	isolated	isolate	VERB
njb-33	146	14	from	from	ADP
njb-33	146	15	urinary	urinary	ADJ
njb-33	146	16	tract	tract	NOUN
njb-33	146	17	infection	infection	NOUN
njb-33	146	18	and	and	CCONJ
njb-33	146	19	their	their	PRON
njb-33	146	20	sensitivity	sensitivity	NOUN
njb-33	146	21	pattern	pattern	NOUN
njb-33	146	22	.	.	PUNCT
njb-33	147	1	j	j	PROPN
njb-33	147	2	nepal	nepal	PROPN
njb-33	147	3	med	me	VERB
njb-33	147	4	assoc	assoc	PROPN
njb-33	147	5	2004,43:200203	2004,43:200203	PROPN
njb-33	147	6	.	.	PUNCT
njb-33	148	1	8	8	X
njb-33	148	2	.	.	X
njb-33	148	3	khanal	khanal	PROPN
njb-33	148	4	s	s	PROPN
njb-33	148	5	:	:	PUNCT
njb-33	148	6	a	a	DET
njb-33	148	7	study	study	NOUN
njb-33	148	8	on	on	ADP
njb-33	148	9	microbiology	microbiology	NOUN
njb-33	148	10	of	of	ADP
njb-33	148	11	urinary	urinary	ADJ
njb-33	148	12	infection	infection	NOUN
njb-33	148	13	at	at	ADP
njb-33	148	14	tribhuvan	tribhuvan	PROPN
njb-33	148	15	university	university	PROPN
njb-33	148	16	teaching	teaching	PROPN
njb-33	148	17	hospital	hospital	PROPN
njb-33	148	18	,	,	PUNCT
njb-33	148	19	kathmandu	kathmandu	PROPN
njb-33	148	20	,	,	PUNCT
njb-33	148	21	nepal	nepal	NOUN
njb-33	148	22	.	.	PUNCT
njb-33	149	1	msc	msc	PROPN
njb-33	149	2	thesis	thesis	NOUN
njb-33	149	3	.	.	PUNCT
njb-33	150	1	tribhuvan	tribhuvan	PROPN
njb-33	150	2	university	university	PROPN
njb-33	150	3	,	,	PUNCT
njb-33	150	4	central	central	ADJ
njb-33	150	5	department	department	NOUN
njb-33	150	6	of	of	ADP
njb-33	150	7	microbiology	microbiology	NOUN
njb-33	150	8	;	;	PUNCT
njb-33	150	9	2006	2006	NUM
njb-33	150	10	.	.	PUNCT
njb-33	151	1	9	9	NUM
njb-33	151	2	.	.	PUNCT
njb-33	151	3	raza	raza	PROPN
njb-33	151	4	s	s	PROPN
njb-33	151	5	,	,	PUNCT
njb-33	151	6	pandey	pandey	PROPN
njb-33	151	7	s	s	PROPN
njb-33	151	8	,	,	PUNCT
njb-33	151	9	bhatt	bhatt	PROPN
njb-33	151	10	cp	cp	PROPN
njb-33	151	11	:	:	PUNCT
njb-33	151	12	microbiological	microbiological	ADJ
njb-33	151	13	analysis	analysis	NOUN
njb-33	151	14	of	of	ADP
njb-33	151	15	the	the	DET
njb-33	151	16	urine	urine	NOUN
njb-33	151	17	isolates	isolate	VERB
njb-33	151	18	in	in	ADP
njb-33	151	19	kathmandu	kathmandu	PROPN
njb-33	151	20	medical	medical	PROPN
njb-33	151	21	college	college	PROPN
njb-33	151	22	teaching	teaching	PROPN
njb-33	151	23	hospital	hospital	PROPN
njb-33	151	24	,	,	PUNCT
njb-33	151	25	kathmandu	kathmandu	PROPN
njb-33	151	26	,	,	PUNCT
njb-33	151	27	nepal	nepal	ADJ
njb-33	151	28	.	.	PUNCT
njb-33	152	1	kathmandu	kathmandu	PROPN
njb-33	152	2	univ	univ	PROPN
njb-33	152	3	med	me	VERB
njb-33	152	4	j	j	PROPN
njb-33	153	1	2011,36(4):295	2011,36(4):295	PROPN
njb-33	153	2	-	-	PUNCT
njb-33	153	3	7	7	NUM
njb-33	153	4	.	.	NUM
njb-33	153	5	10	10	NUM
njb-33	153	6	.	.	PUNCT
njb-33	154	1	patel	patel	PROPN
njb-33	154	2	s	s	PROPN
njb-33	154	3	,	,	PUNCT
njb-33	154	4	taviad	taviad	PROPN
njb-33	154	5	pp	pp	ADV
njb-33	154	6	,	,	PUNCT
njb-33	154	7	sinham	sinham	PROPN
njb-33	154	8	,	,	PUNCT
njb-33	154	9	javadekar	javadekar	PROPN
njb-33	154	10	tb	tb	PROPN
njb-33	154	11	,	,	PUNCT
njb-33	154	12	chaudhari	chaudhari	PROPN
njb-33	154	13	vp	vp	PROPN
njb-33	154	14	:	:	PUNCT
njb-33	154	15	urinary	urinary	ADJ
njb-33	154	16	tract	tract	NOUN
njb-33	154	17	infections	infection	NOUN
njb-33	154	18	(	(	PUNCT
njb-33	154	19	uti	uti	PROPN
njb-33	154	20	)	)	PUNCT
njb-33	154	21	among	among	ADP
njb-33	154	22	patients	patient	NOUN
njb-33	154	23	at	at	ADP
njb-33	154	24	g.g	g.g	PROPN
njb-33	154	25	.	.	PROPN
njb-33	154	26	hospital	hospital	PROPN
njb-33	154	27	&	&	CCONJ
njb-33	154	28	medical	medical	PROPN
njb-33	154	29	college	college	PROPN
njb-33	154	30	,	,	PUNCT
njb-33	154	31	jamnagar	jamnagar	PROPN
njb-33	154	32	.	.	PUNCT
njb-33	155	1	national	national	PROPN
njb-33	155	2	j	j	PROPN
njb-33	155	3	community	community	PROPN
njb-33	155	4	medicine	medicine	PROPN
njb-33	155	5	2012	2012	NUM
njb-33	155	6	,	,	PUNCT
njb-33	155	7	3(1	3(1	PROPN
njb-33	155	8	):	):	PUNCT
njb-33	155	9	138	138	NUM
njb-33	155	10	-	-	SYM
njb-33	155	11	41	41	NUM
njb-33	155	12	.	.	SYM
njb-33	155	13	11	11	NUM
njb-33	155	14	.	.	PUNCT
njb-33	156	1	johnson	johnson	PROPN
njb-33	156	2	jr	jr	PROPN
njb-33	156	3	:	:	PUNCT
njb-33	156	4	virulence	virulence	NOUN
njb-33	156	5	factors	factor	NOUN
njb-33	156	6	in	in	ADP
njb-33	156	7	escherichia	escherichia	NOUN
njb-33	156	8	coli	coli	NOUN
njb-33	156	9	urinary	urinary	ADJ
njb-33	156	10	tract	tract	NOUN
njb-33	156	11	infection	infection	NOUN
njb-33	156	12	.	.	PUNCT
njb-33	157	1	clin	clin	PROPN
njb-33	157	2	microbiol	microbiol	PROPN
njb-33	157	3	rev	rev	PROPN
njb-33	157	4	1991,4:80128	1991,4:80128	NUM
njb-33	157	5	.	.	PUNCT
njb-33	157	6	12	12	NUM
njb-33	157	7	.	.	PUNCT
njb-33	158	1	gautam	gautam	PROPN
njb-33	158	2	k	k	PROPN
njb-33	158	3	,	,	PUNCT
njb-33	158	4	pokhrel	pokhrel	PROPN
njb-33	158	5	bm	bm	PROPN
njb-33	158	6	:	:	PUNCT
njb-33	158	7	prevalence	prevalence	NOUN
njb-33	158	8	of	of	ADP
njb-33	158	9	urinary	urinary	ADJ
njb-33	158	10	tract	tract	NOUN
njb-33	158	11	infection	infection	NOUN
njb-33	158	12	at	at	ADP
njb-33	158	13	kanti	kanti	PROPN
njb-33	158	14	children	children	PROPN
njb-33	158	15	’s	’s	PART
njb-33	158	16	hospital	hospital	NOUN
njb-33	158	17	.	.	PUNCT
njb-33	159	1	j	j	PROPN
njb-33	159	2	chitwan	chitwan	PROPN
njb-33	159	3	medical	medical	PROPN
njb-33	159	4	college	college	PROPN
njb-33	159	5	2012	2012	NUM
njb-33	159	6	,	,	PUNCT
njb-33	159	7	1(2):22	1(2):22	NUM
njb-33	159	8	-	-	SYM
njb-33	159	9	5	5	NUM
njb-33	159	10	.	.	NUM
njb-33	159	11	13	13	NUM
njb-33	159	12	.	.	PUNCT
njb-33	160	1	jha	jha	PROPN
njb-33	160	2	n	n	PROPN
njb-33	160	3	,	,	PUNCT
njb-33	160	4	bapat	bapat	PROPN
njb-33	160	5	sk	sk	PROPN
njb-33	160	6	:	:	PUNCT
njb-33	160	7	a	a	DET
njb-33	160	8	study	study	NOUN
njb-33	160	9	of	of	ADP
njb-33	160	10	sensitivity	sensitivity	NOUN
njb-33	160	11	and	and	CCONJ
njb-33	160	12	resistance	resistance	NOUN
njb-33	160	13	of	of	ADP
njb-33	160	14	pathogenic	pathogenic	ADJ
njb-33	160	15	microorganisms	microorganism	NOUN
njb-33	160	16	causing	cause	VERB
njb-33	160	17	uti	uti	PROPN
njb-33	160	18	in	in	ADP
njb-33	160	19	kathmandu	kathmandu	PROPN
njb-33	160	20	valley	valley	PROPN
njb-33	160	21	.	.	PUNCT
njb-33	161	1	kumj	kumj	PROPN
njb-33	161	2	2005,3:123	2005,3:123	NUM
njb-33	161	3	-	-	SYM
njb-33	161	4	9	9	NUM
njb-33	161	5	.	.	NUM
njb-33	161	6	14	14	NUM
njb-33	161	7	.	.	PUNCT
njb-33	162	1	dalhoff	dalhoff	PROPN
njb-33	162	2	a	a	PRON
njb-33	162	3	:	:	PUNCT
njb-33	162	4	global	global	ADJ
njb-33	162	5	fluoroquinolone	fluoroquinolone	NOUN
njb-33	162	6	resistance	resistance	NOUN
njb-33	162	7	epidemiology	epidemiology	NOUN
njb-33	162	8	and	and	CCONJ
njb-33	162	9	implictions	impliction	NOUN
njb-33	162	10	for	for	ADP
njb-33	162	11	clinical	clinical	ADJ
njb-33	162	12	use	use	NOUN
njb-33	162	13	.	.	PUNCT
njb-33	163	1	interdisciplinary	interdisciplinary	ADJ
njb-33	163	2	perspectives	perspective	NOUN
njb-33	163	3	on	on	ADP
njb-33	163	4	infectious	infectious	ADJ
njb-33	163	5	diseases	disease	NOUN
njb-33	163	6	2012	2012	NUM
njb-33	163	7	,	,	PUNCT
njb-33	163	8	12:37	12:37	NUM
njb-33	163	9	.	.	PUNCT
njb-33	163	10	15	15	NUM
njb-33	163	11	.	.	PUNCT
njb-33	164	1	upadhyay	upadhyay	PROPN
njb-33	164	2	g	g	PROPN
njb-33	164	3	,	,	PUNCT
njb-33	164	4	shakya	shakya	PROPN
njb-33	164	5	g	g	PROPN
njb-33	164	6	,	,	PUNCT
njb-33	164	7	upadhyaya	upadhyaya	PROPN
njb-33	164	8	bp	bp	PROPN
njb-33	164	9	,	,	PUNCT
njb-33	164	10	shrestha	shrestha	PROPN
njb-33	164	11	s	s	PROPN
njb-33	164	12	,	,	PUNCT
njb-33	164	13	ansari	ansari	PROPN
njb-33	164	14	s	s	PROPN
njb-33	164	15	,	,	PUNCT
njb-33	164	16	ghimire	ghimire	PROPN
njb-33	164	17	p	p	PROPN
njb-33	164	18	et	et	X
njb-33	164	19	al	al	PROPN
njb-33	164	20	:	:	PUNCT
njb-33	164	21	comparative	comparative	ADJ
njb-33	164	22	evaluation	evaluation	NOUN
njb-33	164	23	of	of	ADP
njb-33	164	24	urine	urine	NOUN
njb-33	164	25	isolates	isolate	VERB
njb-33	164	26	among	among	ADP
njb-33	164	27	kidney	kidney	NOUN
njb-33	164	28	transplanted	transplanted	PROPN
njb-33	164	29	and	and	CCONJ
njb-33	164	30	other	other	ADJ
njb-33	164	31	uti	uti	PROPN
njb-33	164	32	suspected	suspect	VERB
njb-33	164	33	patients	patient	NOUN
njb-33	164	34	visiting	visit	VERB
njb-33	164	35	national	national	ADJ
njb-33	164	36	public	public	PROPN
njb-33	164	37	health	health	PROPN
njb-33	164	38	laboratory	laboratory	PROPN
njb-33	164	39	,	,	PUNCT
njb-33	164	40	(	(	PUNCT
njb-33	164	41	nphl	nphl	PROPN
njb-33	164	42	)	)	PUNCT
njb-33	164	43	teku	teku	PROPN
njb-33	164	44	,	,	PUNCT
njb-33	164	45	nepal	nepal	ADJ
njb-33	164	46	.	.	PUNCT
njb-33	165	1	int	int	PROPN
njb-33	165	2	j	j	PROPN
njb-33	165	3	biomedical	biomedical	PROPN
njb-33	165	4	and	and	CCONJ
njb-33	165	5	advance	advance	NOUN
njb-33	165	6	research	research	NOUN
njb-33	165	7	2013,4(6):36975	2013,4(6):36975	NUM
njb-33	165	8	.	.	PUNCT
njb-33	166	1	16	16	NUM
njb-33	166	2	.	.	PUNCT
njb-33	167	1	tuladhar	tuladhar	PROPN
njb-33	167	2	nr	nr	PROPN
njb-33	167	3	,	,	PUNCT
njb-33	167	4	banjade	banjade	PROPN
njb-33	167	5	n	n	PROPN
njb-33	167	6	,	,	PUNCT
njb-33	167	7	pokhrel	pokhrel	PROPN
njb-33	167	8	bm	bm	PROPN
njb-33	167	9	,	,	PUNCT
njb-33	167	10	rizal	rizal	PROPN
njb-33	167	11	b	b	PROPN
njb-33	167	12	,	,	PUNCT
njb-33	167	13	manandhar	manandhar	ADJ
njb-33	167	14	r	r	NOUN
njb-33	167	15	,	,	PUNCT
njb-33	167	16	shrestha	shrestha	PROPN
njb-33	167	17	s	s	PROPN
njb-33	167	18	,	,	PUNCT
njb-33	167	19	shah	shah	VERB
njb-33	167	20	a	a	DET
njb-33	167	21	and	and	CCONJ
njb-33	167	22	chaurasia	chaurasia	PROPN
njb-33	167	23	s.	s.	PROPN
njb-33	167	24	antimicrobial	antimicrobial	ADJ
njb-33	167	25	resistant	resistant	ADJ
njb-33	167	26	bacterial	bacterial	ADJ
njb-33	167	27	strains	strain	NOUN
njb-33	167	28	from	from	ADP
njb-33	167	29	inpatients	inpatient	NOUN
njb-33	167	30	of	of	ADP
njb-33	167	31	tribhuvan	tribhuvan	PROPN
njb-33	167	32	university	university	PROPN
njb-33	167	33	teaching	teaching	PROPN
njb-33	167	34	hospital	hospital	NOUN
njb-33	167	35	kathmandu	kathmandu	NOUN
njb-33	167	36	.	.	PUNCT
njb-33	168	1	j	j	PROPN
njb-33	168	2	inst	inst	ADP
njb-33	168	3	med	med	PROPN
njb-33	168	4	2003	2003	NUM
njb-33	168	5	,	,	PUNCT
njb-33	168	6	25:19	25:19	NUM
njb-33	168	7	-	-	SYM
njb-33	168	8	26	26	NUM
njb-33	168	9	.	.	NUM
njb-33	168	10	17	17	NUM
njb-33	168	11	.	.	PUNCT
njb-33	169	1	gautam	gautam	PROPN
njb-33	169	2	r	r	PROPN
njb-33	169	3	,	,	PUNCT
njb-33	169	4	chapagain	chapagain	PROPN
njb-33	169	5	ml	ml	PROPN
njb-33	169	6	,	,	PUNCT
njb-33	169	7	acharya	acharya	VERB
njb-33	169	8	a	a	DET
njb-33	169	9	,	,	PUNCT
njb-33	169	10	rayamajhi	rayamajhi	PROPN
njb-33	169	11	n	n	PROPN
njb-33	169	12	,	,	PUNCT
njb-33	169	13	shrestha	shrestha	PROPN
njb-33	169	14	s	s	PROPN
njb-33	169	15	,	,	PUNCT
njb-33	169	16	ansari	ansari	PROPN
njb-33	169	17	s	s	PROPN
njb-33	169	18	,	,	PUNCT
njb-33	169	19	upadhaya	upadhaya	PROPN
njb-33	169	20	g	g	PROPN
njb-33	169	21	,	,	PUNCT
njb-33	169	22	nepal	nepal	ADJ
njb-33	169	23	hp	hp	PROPN
njb-33	169	24	.	.	NOUN
njb-33	169	25	antimicrobial	antimicrobial	ADJ
njb-33	169	26	susceptibility	susceptibility	NOUN
njb-33	169	27	patterns	pattern	NOUN
njb-33	169	28	of	of	ADP
njb-33	169	29	escherichia	escherichia	NOUN
njb-33	169	30	coli	coli	NOUN
njb-33	169	31	from	from	ADP
njb-33	169	32	various	various	ADJ
njb-33	169	33	clinical	clinical	ADJ
njb-33	169	34	sources	source	NOUN
njb-33	169	35	.	.	PUNCT
njb-33	170	1	jcmc	jcmc	PROPN
njb-33	170	2	2013,3:14	2013,3:14	PROPN
njb-33	170	3	-	-	SYM
njb-33	170	4	7	7	NUM
njb-33	170	5	.	.	NUM
njb-33	170	6	18	18	NUM
njb-33	170	7	.	.	PUNCT
njb-33	171	1	baral	baral	ADJ
njb-33	171	2	r	r	PROPN
njb-33	171	3	,	,	PUNCT
njb-33	171	4	timilsina	timilsina	PROPN
njb-33	171	5	s	s	PROPN
njb-33	171	6	,	,	PUNCT
njb-33	171	7	jha	jha	PROPN
njb-33	171	8	p	p	PROPN
njb-33	171	9	,	,	PUNCT
njb-33	171	10	bhattarai	bhattarai	PROPN
njb-33	172	1	nr	nr	PROPN
njb-33	172	2	,	,	PUNCT
njb-33	172	3	poudyal	poudyal	PROPN
njb-33	172	4	n	n	PROPN
njb-33	172	5	,	,	PUNCT
njb-33	172	6	gurung	gurung	PROPN
njb-33	172	7	r	r	PROPN
njb-33	172	8	,	,	PUNCT
njb-33	172	9	khanal	khanal	PROPN
njb-33	172	10	b	b	PROPN
njb-33	172	11	,	,	PUNCT
njb-33	172	12	bhattachary	bhattachary	ADJ
njb-33	172	13	sk	sk	NOUN
njb-33	172	14	.	.	PROPN
njb-33	172	15	study	study	NOUN
njb-33	172	16	of	of	ADP
njb-33	172	17	antimicrobial	antimicrobial	ADJ
njb-33	172	18	susceptibility	susceptibility	NOUN
njb-33	172	19	pattern	pattern	NOUN
njb-33	172	20	of	of	ADP
njb-33	172	21	gram	gram	ADJ
njb-33	172	22	positive	positive	ADJ
njb-33	172	23	organism	organism	NOUN
njb-33	172	24	causing	cause	VERB
njb-33	172	25	uti	uti	PROPN
njb-33	172	26	in	in	ADP
njb-33	172	27	a	a	DET
njb-33	172	28	tertiary	tertiary	ADJ
njb-33	172	29	care	care	NOUN
njb-33	172	30	hospital	hospital	NOUN
njb-33	172	31	on	on	ADP
njb-33	172	32	eastern	eastern	ADJ
njb-33	172	33	region	region	NOUN
njb-33	172	34	of	of	ADP
njb-33	172	35	nepal	nepal	PROPN
njb-33	172	36	.	.	PUNCT
njb-33	173	1	health	health	NOUN
njb-33	173	2	renaissance	renaissance	PROPN
njb-33	173	3	2013	2013	NUM
njb-33	173	4	,	,	PUNCT
njb-33	173	5	11(1	11(1	NUM
njb-33	173	6	):	):	PUNCT
njb-33	173	7	119	119	NUM
njb-33	173	8	-	-	SYM
njb-33	173	9	24	24	NUM
njb-33	173	10	.	.	PUNCT